<rss version='2.0'>

                    <channel>

                    <title><![CDATA[Central Nervous System Infections]]></title>

                    <link>https://www.benthamscience.com</link>

                    <description>

                    RSS Feed for Disease Wise Article | BenthamScience

                    </description>

                    <generator>EurekaSelect (+http://eurekaselect.com)</generator>

                    <pubDate>Wed, 15 Apr 2026 13:34:01 +0000</pubDate>

                    <image>

                    <title><![CDATA[Central Nervous System Infections]]></title>

                    <url>https://www.benthamscience.com</url>

                    <link>https://www.benthamscience.com</link>

                    </image><item><title><![CDATA[Parasites in the Nervous System]]></title><link>https://www.benthamscience.comchapter/24916</link><description><![CDATA[Parasitic disease of the nervous system of cattle is generally caused by migrating nematodes, cestode cysts, or protozoa in the central nervous system. The parasites namely Hypoderma larvae cause neurological diseases. The toxins liberated by <i>Dermacentor</i> ticks, and metabolic changes associated with intestinal coccidiosis are the key factors for neurological complications.]]></description> </item><item><title><![CDATA[Parasitic Infection of the Nervous System of Goats]]></title><link>https://www.benthamscience.comchapter/24040</link><description><![CDATA[The nervous system may be the primary or secondary site of parasitic infection; parasitic diseases may occur as opportunistic infections or arise in immunecompetent hosts. Parasitic infections cause a major economic impact on the farm goats industry, especially the infected central nervous system, as they cause a group of neurological diseases and constitute the biggest single and only challenge for veterinarians. The neurological health problems caused by these parasites affect goats as an outbreak in an endemic area or as sporadic cases in no endemic areas because of a decrease in good management, and immunosuppression caused by different stress as (transportation, grassing, pregnancy, and other risk factors). Parasites are a diverse group of organisms that can be broadly classified into single-celled organisms (i.e. protozoa) or multicellular helminthes (i.e. metazoan). Parasites can cause disease by physical disruption of tissue as they migrate, inflammatory response, provoking an intense, and often eosinophilia, some helminthic larvae can be very large, causing disease because of their expanding mass. A relatively large number of parasites are zoonotic and transmitted to humans, sometimes migrating through or lodging in tissues, including the CNS. Some parasites regularly cause symptomatic disease, while others cause asymptomatic diseases. Most goats through the word carry worms. However, the extent of their effect on goats in terms of deaths, loss of productivity, and the cost of control depends on the severity of the infestation and the species of the parasite, where goats are less able to develop natural immunity compared with other livestock species. Most common parasites have two stages of development: the larval stage, which may develop on pasture or tissue of goats as intermediate host, and the adult parasitic stage, which occurs in the intestine of goats or another definitive host.]]></description> </item><item><title><![CDATA[Molecular Basis of Hepatitis C]]></title><link>https://www.benthamscience.comchapter/22296</link><description><![CDATA[Hepatitis C virus (HCV) is a significant cause of chronic liver disease worldwide. The molecular basis of HCV infection and replication has been extensively studied, leading to the identification of vital viral proteins and their interactions with host factors. The HCV genome encodes a single polyprotein cleaved by host and viral proteases into individual proteins, including the core, envelope glycoproteins (E1 and E2), p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B. These viral proteins play critical roles in virus assembly, entry, replication, and evasion of host immune responses. The HCV envelope glycoproteins E1 and E2 are responsible for virus attachment and entry into host cells through interactions with various host receptors, including CD81, scavenger receptor class B type I (SR-BI), and tight junction proteins. The viral protein NS3 has multiple functions, including protease and helicase activities, which are critical for viral RNA replication. NS5A is an essential component of the viral replication complex and regulates viral RNA replication, virion assembly, and modulation of host immune responses. NS5B is the RNA-dependent RNA polymerase responsible for viral RNA synthesis. The molecular mechanisms underlying HCVinduced pathogenesis and the development of chronic infection remain poorly understood. However, recent studies have shed light on the interactions between HCV and host factors, including the innate and adaptive immune responses and the roles of viral proteins in modulating these responses. These insights have led to new antiviral therapies, including direct-acting antivirals (DAAs) that target viral proteins in RNA replication.&nbsp;<br>]]></description> </item><item><title><![CDATA[The Geriatric COVID Patient]]></title><link>https://www.benthamscience.comchapter/22213</link><description><![CDATA[The COVID-19 pandemic resulted in a significant impact on healthcare across the world. The pandemic is caused by the coronavirus SARS-CoV-2 and is transmitted through respiratory secretions. The geriatric population comprised most morbidities and mortalities related to COVID-19. Common symptoms include fever, cough, dyspnea, myalgia, and culminating in acute hypoxic respiratory failure and acute myocardial injury. Geriatric patients with COVID-19 who require surgery are at a greater risk of postoperative complications. An assessment of the risks and benefits of surgical intervention relies on the degree of COVID-19 pathology and the type of surgery whether emergent or elective. The presence of COVID-19 does not warrant a change in the modality of anesthesia that would be performed for any given surgery in the absence of COVID-19.<br>]]></description> </item><item><title><![CDATA[Anesthetic Considerations for Patients with Chronic Neurologic Disorders]]></title><link>https://www.benthamscience.comchapter/22209</link><description><![CDATA[Chronic neurological disorders encompass a broad range of challenges for the surgical and anesthesiology team in the perioperative setting. According to the World Population Prospects 2019, by 2050, 1 in 6 people will be over 65, from 1 in 11 in 2019 [1]. As our population continues to age, our understanding and ability to provide medical and surgical services must improve as well. Perioperative strokes are rare, but they can greatly impact a patient's recovery and function when they occur. Dementia strongly predicts postoperative complications, higher hospital costs, and 30- day mortality [2]. Patients with Parkinson’s disease are at a higher risk of perioperative medical and surgical complications not to mention specific medication regimens that need to be adjusted to avoid worsening symptomatology. Although rare, a patient presenting with Amyotrophic lateral sclerosis (ALS), can present with a broad range of neurologic symptoms, and cardiovascular and pulmonary dysfunction that can be daunting for any anesthesia provider. In this chapter, we will explore the comprehensive approach to managing chronic neurologic disorders, including multidisciplinary care, early identification of potential complications, specialized medication management, and intraoperative considerations.<br>]]></description> </item><item><title><![CDATA[Geriatric Pain Patient]]></title><link>https://www.benthamscience.comchapter/22205</link><description><![CDATA[Chronic pain is a major cause of physical disability, poor mental health, and decreased quality of life [1,2]. The burden of chronic pain is reflected in increased medical care utilization and consequently increased healthcare costs, which are estimated at an astounding $560 billion per year [3]. CDC estimates from 2019 reveal that while 20.4% of adults in the USA live with chronic pain, the prevalence increases with advancing age [4]. 30.8% of people aged 65 years and above had chronic pain while 11.8% of them had high-impact chronic pain, which is defined as pain that causes significant restriction of self-care, social and work-related activities [5]. The impact of chronic pain is more severe in the elderly; older adults report poorer physical health and disability in comparison to younger adults [6-8]. Chronic pain in the elderly is also associated with poorer sleep, cognitive decline, dementia, and death [9-13]. With the projected increase in the elderly population in the US every year, the burden of chronic pain is only expected to increase. This chapter outlines the physiologic and pharmacologic changes that happen with ageing, the major causes of chronic pain in the elderly, as well as the myriad of treatment options available with a focus on pharmacotherapy, behavioral and alternative therapies, and interventional pain therapies. The focus of treatment is not only targeted towards reducing pain but special considerations should be made to minimize the cognitive effects of polypharmacy in light of multiple comorbidities and promote mental well-being and functional independence [14].<br>]]></description> </item><item><title><![CDATA[Anatomical and Physiological Changes in Aging]]></title><link>https://www.benthamscience.comchapter/22196</link><description><![CDATA[The human body is a complex connection of various systems, each affected by the internal and external environment. Each system relies on the other and changes in one can result in variations in all other organ systems. As humans age, their physical appearance changes, but the aging process also occurs below the skin. Each organ system is impacted by time, and an individual’s lifestyle can greatly impact his/her organ system. Various anatomical and physiological alterations that occur to the major organ systems due to aging and are relevant to an anesthesiologist are discussed below.<br>]]></description> </item><item><title><![CDATA[Therapeutic Applications and Pharmacological Practices of Essential Oils]]></title><link>https://www.benthamscience.comchapter/22104</link><description><![CDATA[When referring to a drug's active component as “Quinta essential,” Paracelsus von Hohenheim, a Swiss physician used the word “essential oil” for the very first time in the sixteenth century. Plant oils and extracts have been utilised for a variety of purposes for thousands of years. Essential oils have long been used in traditional medicine and by practitioners of alternative rejuvenation approaches. Because of their considerable immunomodulatory and antibacterial action, they have been used for many years to treat various ailments. Many volatile chemicals generated by plant secondary metabolism combine to make essential oils. Components of essential oil may be classified into two related types on a biosynthetic level. The two primary groups are terpene or terpenoid inchoation compounds, as well as aromatic and aliphatic components. Since the Middle Ages, essential oils have been utilized for antibacterial, biocidal, anti-fungal, antiprotozoal, and antifeedant purposes, as well as painkiller, calming, anti-inflammatory, anti-spasmodic, and locally anesthetic therapy.<br><br>However, little is understood about how essential oils function. Plant oils and extracts' antimicrobial characteristics have served as the foundation for a variety of enterprises, including pharmaceuticals, alternative medicine, and herbal treatments. <br>]]></description> </item><item><title><![CDATA[Plant as Potential Resources for Efficacious Essential Oils: Underpinning Aromatherapy Evolution]]></title><link>https://www.benthamscience.comchapter/22099</link><description><![CDATA[The basis of healthcare has been medicinal plants from the dawn of humanity. For over 4000 years, people have carefully documented and passed down through generations the various ways in which these have been utilized. The Indian Vedic literature, which dates to roughly 2000 BC, contains a list of around 700 compounds. Cinnamon, spikenard, ginger, myrrh, coriander, and sandalwood are a few of these. Since ancient times, aromatic plant parts and oils have been used for their therapeutic and culinary characteristics, as well as to produce incense, perfumes, cosmetics, and for incense sticks. Ritual use was widespread in early cultures, where it served both sacred and therapeutic objectives that were intricately intertwined. Since prehistoric times, plant essential oils have been utilized in foods, aromatherapy, perfumes, cosmetics, spices, and alimentation. They have also been applied in other medical procedures and phytotherapy. In the current era of pharmaceutical science, interest in herbal medicines has grown relative to conventional or synthetic treatments because they are more affordable, more widely accepted, compatible with human physiology, and have fewer adverse effects. The medicinal properties and applications of an expanding number of emerging essential oils have been researched and documented by pharmacists. The interest in analysing their bioactivity has progressed owing to their widespread use, particularly the recently investigated antibacterial, antioxidant, anticancer, and antidiabetic effects. The traditional Indian or Ayurvedic system of medicine, as well as other ecumenical customary systems, would be transformed if plant predicated knowledge were to be incorporated. The uses of numerous plants for therapeutic, medical, aesthetic, psychological, olfactory, massage, aromatherapy, and other associated issues are examined in this chapter.<br>]]></description> </item><item><title><![CDATA[Subject Index]]></title><link>https://www.benthamscience.comchapter/21919</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Inflammasomes, Inflammation and Neuropathic Pain]]></title><link>https://www.benthamscience.comchapter/21918</link><description><![CDATA[Inflammasomes such as NOD-like receptor protein 1 (NLRP1), NLRP3, NLR family CARD domain-containing protein 4 (NLRC4) and absent in melanoma 2 (AIM2) are the primary mediators of inflammation and its associated neuropathic pain. These inflammasomes are activated leading to various autoimmune &amp; metabolic disorders, cancer, and other inflammatory diseases. The activation of inflammasomes occurs due to molecular alterations like mitochondrial dysfunction, neuroinflammation, lysosomal damage, oxidative stress, sensitization, and disinhibition, which lead to proinflammatory pathways causing inflammasome-related neuropathic pain. Among these inflammasomes, NLRP3 has been widely studied and proven to be the key player in the development of neuropathy. In this chapter, we have summarized the role of inflammasome and how NLRP3 is involved in neuropathic pain. Therefore, based on the facts available, it has been suggested that focusing on inflammasome activity may be a cutting-edge and successful treatment approach for neuropathic pain.&nbsp;<br>]]></description> </item><item><title><![CDATA[The NLRP3 Inflammasome as a Target for Antiinflammatory Drugs]]></title><link>https://www.benthamscience.comchapter/21916</link><description><![CDATA[The Nod-like receptor protein 3 (NLRP3) inflammasome plays a vital role in the nonspecific immune response to inflammatory triggers such as cellular infections, injury, or stressors, and it has also been associated with several inflammation-related diseases. NLRP3 inflammasome activation results in the production of proinflammatory cytokines, contributing to an increased risk of inflammatory conditions, such as cardiovascular, metabolic, infectious, and neurodegenerative diseases. Several signaling pathways and cellular events involved in the NLRP3 inflammasome assembly and activation have been studied, and inhibitory mechanisms have been identified. NLRP3 inflammasome inhibition decreases inflammation and inflammasome-mediated cell death. In prospecting for novel anti-inflammatory therapeutics, signaling molecules upstream or downstream on the NLRP3 inflammasome pathway can serve as viable drug targets. Effective inhibition of these molecules culminates in the downregulation of the expression of proinflammatory cytokines like interleukin-1beta (IL-1β) and IL-18. This chapter elucidates the various classes of NLRP3 inflammasome inhibitors, their resultant anti-inflammatory effects, and various mechanisms of action. <br>]]></description> </item><item><title><![CDATA[Subject Index]]></title><link>https://www.benthamscience.comchapter/21907</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Immunomodulating Botanicals: An Overview of the Bioactive Phytochemicals for the Management of Autoimmune Disorders]]></title><link>https://www.benthamscience.comchapter/21851</link><description><![CDATA[Immunomodulation refers to the mechanism by which the response of the immune system is modified by the regulation of antibody synthesis, leading to either an increase or a decrease in its levels in the circulation and body organs. Owing to their immunomodulation and remedial benefits, a broad range of herbal remedies have been shown to be effective in the treatment of autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, myasthenia gravis, and systemic lupus erythematosus. The ancient Indian system of Ayurveda and different other alternative therapeutic methods have acknowledged the potential benefits of herbal-based remedies to upregulate or suppress the immune response in the human body. The conventional pharmacotherapies used for the management of autoimmune ailments are documented to cause serious drug-induced adverse reactions (ADRs). Whereas, some phytotherapies have proven safe, reliable, and efficient alternatives for the existing drug regimens with lesser ADRs. For instance, Withania somnifera, Andrographis paniculate, Tinospora cordifolia, Glycyrrhiza glabra, and Berberis arista are a few herbs whose bioactive phytoconstituents have been reported to possess powerful immunomodulation properties. Based on their purported immunomodulatory mechanisms, they can be used for the management of autoimmune conditions. The focus of this review is to highlight the key inflammatory biomarkers such as TNF-α and interleukin 1, 6 involved in the distortion of the immune system in humans. Also, we will discuss the usefulness of animal models for understanding the underlying mechanisms of autoimmune disorders. In addition, we will describe the patents of phytomedicine formulations filed by different manufacturers for the management of autoimmune disorders, as well as futuristic opportunities that should be explored for discovering the therapeutic functions of alternate remedies for treating autoimmune diseases.<br>]]></description> </item><item><title><![CDATA[Food Color, Taste, Smell, Culinary Plate, Flavor, Locale, and their Impact on Nutrition: Present and Future Multisensory Food Augmentation and Noncommunicable Disease Prevention: An Overview]]></title><link>https://www.benthamscience.comchapter/21844</link><description><![CDATA[Cognizant that ‘the world is one family’, this overview describes chemosensory characteristics of food and related issues that may enable global inequalities in healthy food consumption to be improved with a reduction in noncommunicable diseases (NCDs), preventatively. Past and modern aspects of food tradition are briefly described followed by titular chemosensory characteristics and their potential application to improving health in nutrition in the sense intended, including the culinary plate. Human-computer interface and food augmentation reality and commensal dining, in association with chemosensory properties, including sound concerning oral food processing, are described. Future research on arresting trends in the prevalence of NCD is suggested based on the literature. Visual cues for in-store food choice are discussed that potentially allow the consumer, through psychological processes and behavior outcomes, to be more discerning. Advertisements and store architecture per se are not discussed. The relatively high prevalence of anosmia caused by COVID-19 infection relative to non-infected subjects may alter taste and flavor perception and lead to changed dietary habits and metabolism. Most global consumers can practice the ‘how’ and ‘when’ to beneficially eat but food insecurity poses a global problem.<br>]]></description> </item><item><title><![CDATA[Pediatric Morphea]]></title><link>https://www.benthamscience.comchapter/21786</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Parry-Romberg Syndrome]]></title><link>https://www.benthamscience.comchapter/21784</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Associated Diseases]]></title><link>https://www.benthamscience.comchapter/21777</link><description><![CDATA[]]></description> </item><item><title><![CDATA[The Role of Age in Pediatric Tumors of the Central Nervous System]]></title><link>https://www.benthamscience.comchapter/21742</link><description><![CDATA[Pediatric tumors of the central nervous system (CNS) are the second most common type of solid childhood cancer. As such, they have a major effect on the rates of morbidity and mortality in children. CNS tumors originate from abnormal cells in the brain and/or spinal cord, which can be classified as either benign or malignant. They can be further subdivided into different categories based on several principal aspects, such as tumor location, histopathology, and developmental age. Among these various characteristics, age is one of the most consequential determinants for CNS tumors. Specific groups between 0 and 21 years of age, for instance, have radically divergent landscapes in terms of their tumor incidence and unique biology. Depending on the age of the child, key case features may differ like the clinical evaluation, medical diagnosis and prognosis, recommended therapy and treatment courses, anticipated responses and tolerability to treatment, and management of side effects. Effective teamwork is another crucial component for the successful management of pediatric CNS tumors. In patient-and-family-centered care, ensuring a detailed education of the children and their families, as well as their involvement in the decision-making process where appropriate, is imperative. To determine the best available options for the patient, multidisciplinary medical teams will often deliberate over all of the possible procedures. The holistic care provided by these interprofessional collaborations for this vulnerable population will depend on the age of the child, in addition to the level of patient and family participation. Evidence shows that support and counseling of the patient and their family during the entire treatment process can have a significant impact on outcomes. This chapter will review the essential diagnostic and prognostic considerations of childhood CNS tumors, with special emphasis placed on favorable therapies and treatments, including in-depth discussions around the multi-faceted responses to treatment and the management of its side effects. In particular, this content will highlight the critical role that age, and interdisciplinary healthcare teams play in comprehensive disease management.<br>]]></description> </item><item><title><![CDATA[Role of Gut Microbiota in Neuroinflammation and Neurological Disorders]]></title><link>https://www.benthamscience.comchapter/21741</link><description><![CDATA[The prevalence of neurological diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Multiple sclerosis (MS) are growing in the world, but their pathogenesis is unclear and effective treatment does not exist. Neuroinflammation is associated with many neurodegenerative mechanisms involved in neurodegenerative diseases. The human gut microbiota is an aggregate of microorganisms that live in the gastrointestinal tract (GIT) that plays a crucial role in maintaining human health and the pathogenesis disease condition. The microbiota can affect neuronal function through neurotransmitters, vitamins, and neuroactive microbial metabolites like shortchain fatty acids. The change in gut microbiota architecture causes increased permeability of the intestine and immune system activation, contributing to systemic inflammation, neurological injury, and eventually neurodegeneration. Available data suggest that the microbiota send signals to the central nervous system (CNS) by activating afferent neurons of the vagus nerve via neuroendocrine and neuroimmune pathways. The molecular interaction between the gut/microbiome and CNS is complex and bidirectional, ensuring gut homeostasis and proper digestion. Evidence suggests that dysfunction of the gut-brain axis could be a significant factor leading to many disorders of CNS. In this chapter, we explore how the gut microbiome may affect brain function and the development of neurological disorders. In addition, we are also trying to highlight the recent advances in improving neurological disease by supplemental probiotics and faecal microbiota transplantation via the concept of the gut-brain axis to combat brain-related dysfunction.<br>]]></description> </item><item><title><![CDATA[Neurobiology of Placebo: Interpreting its Evolutionary Origin, Meaning, Mechanisms, Monitoring, and Implications in Therapeutics]]></title><link>https://www.benthamscience.comchapter/21740</link><description><![CDATA[Placebo is defined as the therapeutic response to inert treatment. However, this is a bit simplistic because comprehending the biological basis of the placebo effect requires understanding the entire therapeutic context and the patient immersed in it. Placebo does not cure the disease but alleviates symptoms. The placebo impact must be seen in the context of the recipients’ cultural milieu, psychosocial background, the tone and tenor of the accompanying verbal communication (caring, indifferent, unfriendly), therapeutic rituals (e.g., tablet, injection, or a procedure, including diagnostic tests), symbols (white coat, syringe, the diagnostic paraphernalia), and its meanings to the patient (past experiences and personal hope). Placebo is the inert treatment juxtaposed against the broad context of the accompanying sensory and sociocultural inputs that signal benefit. It could also be the harm in the case of nocebo. A major objective of a standard clinical trial is to eliminate or at least minimise the influence of placebo. Many methods have been devised to measure and eliminate placebo responders in the trial populations. The neurological basis of the placebo effect is complex and must have an evolutionary basis because the susceptibility to placebos may be traced back to animals and birds. The placebo effect probably owes its evolutionary origin to signalling sickness and the ability to draw comfort from winning sympathetic attention and care from conspecifics. Pain being a complex sensory experience with a strong affective component, the neuronal pathways that reflect both sensory experience and the affective components have been explored in the study of the placebo effect. Placebo research, having expanded from psychology to neurology, presently involves research tools that include pharmacology, brain imaging, genetics, animal models, etc. This review will discuss multiple dimensions of the placebo effect, including evolutionary, cultural, psychosocial, and neurological aspects, in addition to providing cues for transformational implications in clinical trials and therapeutic modalities that benefit&nbsp;society. Contemporary medicine is demonising placebo because it is a confounder in clinical trials. It would be much more useful if the healthcare system can harness the therapeutic potential of the placebo effect by manipulating the therapeutic context.<br>]]></description> </item><item><title><![CDATA[Recent Drugs Tested in Clinical Trials for Alzheimer´s and Parkinson´s Diseases Treatment: Current Approaches in Tracking New Drugs]]></title><link>https://www.benthamscience.comchapter/21739</link><description><![CDATA[Affecting more than 50 million people worldwide and with high global costs annually, neurological disorders such as Alzheimer's disease (AD) and Parkinson’s disease (PD) are a growing challenge all over the world. Globally, only in 2018, AD costs reached an astonishing $ 1 trillion and, since the annual costs of AD are rapidly increasing, the projections estimate that these numbers will double by 2030. Considering the industrial perspective, the costs related to the development of new drugs are extremely high when compared to the expected financial return. One of the aggravating factors is the exorbitant values for the synthesis of chemical compounds, hindering the process of searching for new drug candidates. In the last 10-year period, an average of 20 to 40 new drugs were approved per year, representing a success rate of less than 6%. However, the number of referrals for new drug orders and/or applications remained at approximately 700 each year, reinforcing the difficulty in the process of identifying and developing novel drugs. Regarding neurodegenerative diseases, the FDA (USA) approved 53 new therapies in 2019, including 48 new molecules and, from these, three are medicines and two are vaccines. The main drugs recommended for the treatment of these disorders are included in the following classes: Dopamine supplement (Levodopa), Monoamine oxidase (MAO) inhibitor (Selegiline, Rasagiline), Dopamine agonist (Apomorphine, Pramipexole), and Acetylcholinesterase inhibitor (Donepezil, Rivastigmine, Galantamine). Additionally, the current pharmacological treatments are not able to cure these patients and considering the etiological complexity and the prevalence of neurological disorders, scientists have a great challenge in exploring new therapies and new molecules to find an adequate and viable treatment for these diseases. Clinical trials are essential in this process and thus, this chapter describes the most important drugs that were targets of phase III and IV clinical studies in the last five years, associated with the most common neurological disorders worldwide, AD and PD. Information about mechanisms of action, experimental studies in other diseases that support their use, and chemical structure of the drugs are included in this chapter. Additionally, nature as a source of valuable chemical entities for PD and AD therapeutics was also revised, as well as future advances in the field regarding tracking new drugs to get successful results and critical opinions in the research and clinical investigation.<br>]]></description> </item><item><title><![CDATA[Biomaterials and Mesenchymal Stem Cells]]></title><link>https://www.benthamscience.comchapter/21645</link><description><![CDATA[Mesenchymal stem/stromal cells are splendid cell sources for tissue engineering and regenerative medicine attributed to the unique hematopoietic-support and immunomodulatory properties as well as the multi-dimensional differentiation potential towards adipocytes, osteoblasts, and chondrocytes in vitro and in vivo. To date, MSCs have been identified from various approaches, such as perinatal tissues, and adult tissues, and even derived from human pluripotent stem cells (hPSCs). Longitudinal studies have indicated the ameliorative effect and therapeutic efficacy upon a variety of refractory and recurrent disorders such as acute-on-chronic liver failure (ACLF), acute myeloid leukemia (ACLF), premature ovarian failure (POF), and intractable wounds. To date, MSCs have been a to have various origins, including mesoderm, endoderm and ectoderm. In this chapter, we mainly focus on the concepts, and biological and therapeutic properties of MSCs, together with the standardizations for industrial transformation. Overall, the descriptions would help promote a better understanding of MSCs in disease pathogenesis and management and benefit the preclinical and clinical applications in the future.<br>]]></description> </item><item><title><![CDATA[Effective Automated Medical Image Segmentation Using Hybrid Computational Intelligence Technique]]></title><link>https://www.benthamscience.comchapter/21621</link><description><![CDATA[In biomedical domain, magnetic resonance imaging (MRI) segmentation is highly essential for the treatment or prevention of disease. The demand for fast processing and high accurate results is necessary for medical diagnosis. This can be solved by using computational intelligence (CoIn) for data processing. The CoIn can be achieved by using well-known techniques such as fuzzy logic, genetic algorithm, evolutionary algorithms and neural networks. The computational complexity of a medical image segmentation depends on the characteristics of data as well as suitable algorithms. The selection of CoIn methods is very important for better segmentation of a medical image because each algorithm outperforms a different medical image data set. The hybrid CoIn (H-CoIn) is one of the solutions to overcome the problem of individual algorithms in medical image segmentation. The H-CoIn is a combination of two or more intelligence algorithms (like fuzzy logic, evolutionary algorithms and neural networks). The drawbacks of individual intelligence algorithms can be overcome by using H-CoIn. In a medical image segmentation process, two or more variables or objectives need to be optimized for H-CoIn. This problem can be solved by using multi-objective optimization techniques, where simultaneously minimization or maximization can be performed. In this chapter, the various CoIn algorithms' performance has been discussed in detail for medical image segmentation and compared with state-of-the-art techniques. The H-Coin algorithm has been implemented in a large medical dataset and attained an accuracy of 98.89%. Further, the H-Coin algorithm is reliable and suitable to overcome the inter-observer and intraobserver variability.&nbsp;<br>]]></description> </item><item><title><![CDATA[Promising Pharmaceutical Compounds of Marine Bryozoans: Their Chemistry and Therapeutic Applications]]></title><link>https://www.benthamscience.comchapter/21599</link><description><![CDATA[This chapter deals with the pharmaceutically important marine bryozoans, their promising secondary metabolites, and bioactivities. All the bioactive compounds of this marine invertebrate group are dealt with as per their chemical classes.<br>]]></description> </item><item><title><![CDATA[Hormoneal Therapy]]></title><link>https://www.benthamscience.comchapter/21551</link><description><![CDATA[Treatments that involve the use of hormones or their antagonists are commonly referred to as hormone therapy or hormonal therapy. Oncologic hormone therapy, hormone replacement therapy (HRT), androgen replacement therapy (ART), oral contraceptive pills and gender-affirming hormone therapy are the major classes of hormonal therapy in addition to a few others. Some hormonal therapies will be discussed in detail under different chapters including oncologic hormone therapy, glucocorticoids and mineralocorticoids and insulin under antineoplastic agents, antiinflammatory steroids and antidiabetic agents, respectively. After studying this chapter, students will be able to: <br><br>• Define and classify hormonal therapy and differentiate between hormonal therapy and treatment. <br><br>• Explain all types of hormone replacement therapy including menopausal, androgens, and oral contraceptives.<br><br>&nbsp;• Discuss the use of androgen replacement therapy (ART) in males with low levels of testosterone due to disease or aging. <br><br>• Describe gender-affirming hormone therapy such as feminizing hormone therapy and masculinizing hormone therapy. • Identify appropriate growth hormone therapy for growth hormone deficiency. <br><br>• Demonstrate understanding of thyroid hormone replacement in hypothyroidism and antithyroid therapy in hyperthyroidism. <br><br>• Demonstrate clear guidance to the use of oral contraceptive pills for various purposes including birth control.&nbsp;<br>]]></description> </item><item><title><![CDATA[Lactic Acid Bacteria as Starter Cultures in Food: Genome Characterization and Comparative Genomics]]></title><link>https://www.benthamscience.comchapter/21515</link><description><![CDATA[Fermented food products are consumed by about 30% of the world's population due to their high nutritional value and health properties. The use of LAB in the fermentation process has resulted in a variety of fermented food products derived from both plant and animal sources. LAB have been used as starter cultures for food fermentation both traditionally and industrially, having certain specific characteristics such as rapid growth, product yield, higher biomass and also unique organoleptic properties, and are employed in food fermentation. The advancement of highthroughput genome sequencing methods has resulted in a tremendous improvement in our understanding of LAB physiology and has become more essential in the field of food microbiology. The complete genome sequence of Lactococcus lactis in 2001 resulted in a better understanding of metabolic properties and industrial applications of LAB. Genes associated with β-galactosidase, antimicrobial agents, bile salt hydrolase, exopolysaccharide, and GABA producing LAB have received a lot of attention in recent years. Genome editing techniques are required for the development of strains for novel applications and products. They can also play an important part as a research method for acquiring mechanistic insights and identifying new properties. The genome editing of lactic acid bacterial strains has a lot of potential applications for developing functional foods with a favourable influence on the food industries.<br>]]></description> </item><item><title><![CDATA[Promising Nano-Carriers-Based Targeted Drug Delivery Approaches for the Effective Treatment of Alzheimer’s Disease]]></title><link>https://www.benthamscience.comchapter/21417</link><description><![CDATA[Alzheimer’s disease (AD) is an attained disorder of cognitive and behavioral impingement with progressive symptoms over time. It is mostly witnessed in elderly people, and as per the World Health Organization (WHO), it has affected more than 35 million people worldwide, and this figure is presumed to double by the year 2050. The most commonly believed cause of AD is the accumulation of beta-amyloid, which forms extracellular plaques. Presently conventional therapy for treating cognitive impairments in AD relies on a neurotransmitter or enzyme modulation strategy. Conventional approved drugs, such as acetylcholinesterase inhibitors (memantine, tacrine), are widely available for the treatment of mild to moderate AD, but due to their lower bioavailability, poor solubility, and ineffective capability to surpass the blood brain barrier (BBB), they often fail to produce the desired effect. The potency of conventional AD drugs is highly dependent on various physiological aspects such as BBB; blood-cerebrospinal fluid barrier and drug efflux by P-glycoprotein, which all hampers the capabilities of AD drugs to grasp the central nervous system (CNS). So, in order to conquer the hurdle and these existing limitations faced by CNS drugs to cross the BBB, innovative pathways in drug development have become the need of the hour. Various nanocarriers based approaches profitably meet this demand by improving the efficacy as well as facilitating the sustained release of the entrapped AD drug via targeted drug delivery. The blood-brain barrier offers protection to the central nervous system and also limits the entry of therapeutic molecules to the CNS. On the other hand, nanotechnology offers the possibility to deliver small molecules against CNS disorders across BBB due to their enormous properties, such as small surface area, controllable physicochemical properties, higher drug payload, and better drug circulation time. Plenty of nanocarriers and nanoparticle prodrugs have been reported to have inconsequential cytotoxicity in preclinical studies, and these advancements have proclaimed a new juncture for the development of new classes of nano carriers’ based potent drug formulations for the treatment of AD. A plethora of nanotechnology-based approaches such as polymers, emulsions, lipo-carriers, solid lipid carriers, carbon nanotubes, and metal-based carriers have been redefined over time, and they have been successfully focusing on both neuroprotective and neurogenerative techniques for treating AD. Many researchers also reported that nanotechnological-based techniques can improve the early diagnosis of AD and enhance the therapeutic efficacy and bioavailability of drugs.<br>]]></description> </item><item><title><![CDATA[Nano Elicitors and Bioactive Plant Metabolites]]></title><link>https://www.benthamscience.comchapter/21250</link><description><![CDATA[<div>Nature has given plants the ability to produce a wide variety of secondary</div><div>metabolites including alkaloids, phenolics, terpenoids and saponins. These metabolites</div><div>provide them a defense mechanism against biological and non-biological stress factors.</div><div>On the other hand, the same metabolites have proved to be effective against different</div><div>dreadful human diseases. The efficacy of such metabolites ranges from antimicrobial to</div><div>anticancerous effects. Bioactivity-guided characterization is one of the useful strategies</div><div>that have been employed to identify, purify and characterize active components. These</div><div>bioactive components have proved useful in future drug discovery. Elicitors are defined</div><div>as signaling metabolites with the ability to induce biochemical and physiological</div><div>processes in plants resulting in the activation of plants defense mechanisms. Elicitation</div><div>is a useful tool as it leads to the generation of stress conditions and hence the</div><div>accumulation of bioactive secondary metabolites in plants. Various strategies have</div><div>been adopted to enhance the production of bioactive secondary metabolites including</div><div>plant cell and tissue culture and use of signaling metabolites. Nowadays, nano-elicitors</div><div>have emerged as an effective tool to enhance the production of pharmacologically</div><div>important compounds. Various classes of nanoparticles (NPs) have been reported to be</div><div>utilized as nano-elicitors like metallic NPs, metallic oxide NPs and carbon nanotubes</div><div>with positive effects on phytochemical profile. The possible mechanism of</div><div>nanomaterials as elicitors is the interaction with plant genomes by increasing the</div><div>expression level of genes involved in the biosynthesis of active metabolites. Despite</div><div>triggering biosynthetic potential of plants, certain negative effects have been observed</div><div>in plants’ primary metabolism like lower chlorophyll content, a decrease in cell</div><div>viability, a decline in sugar content and suppressed seed germination. Thus, there is a</div><div>need to develop biocompatible nanoparticles for use as nanoelicitors in plants to avoid</div><div>the negative impacts of the used entities.</div>]]></description> </item><item><title><![CDATA[Anticancer Activity of Medicinal Plants Extract and Molecular Docking Studies]]></title><link>https://www.benthamscience.comchapter/21055</link><description><![CDATA[Molecular docking involves the interaction of a molecule with another place, usually in the protein structure, and simulating the placement of the molecule in the protein structure with certain score algorithms, taking into account many quantities, such as the electro-negativity of atoms, their positions to each other, and the conformation of the molecule to be inserted into the protein structure. Finally, the activity of the molecule with the highest percentage by mass against various cancer proteins was investigated according to the GC-MS results made on some medicinal and aromatic plants in order to set an example of molecular docking calculations.<br>]]></description> </item><item><title><![CDATA[Neurological Examination]]></title><link>https://www.benthamscience.comchapter/20987</link><description><![CDATA[A neurological exam, also called a neuro exam, is an evaluation of a person's nervous system that can be done in the physcians. It may be done with instruments, such as lights and reflex hammers. It usually does not cause any pain to the patient. The nervous system consists of the brain, the spinal cord, and the nerves from these areas. There are many aspects of this exam, including an assessment of motor and sensory skills, balance and coordination, mental status (the patient's level of awareness and interaction with the environment), reflexes, and functioning of the nerves. The extent of the exam depends on many factors, including the initial problem that the patient is experiencing, the age of the patient, and the condition of the patient.&nbsp;<br>]]></description> </item><item><title><![CDATA[Radiation from Mobile Phones and Cell Towers, Risks, and Protection]]></title><link>https://www.benthamscience.comchapter/20866</link><description><![CDATA[Modern life is strongly associated with new technologies such as telecommunication and wireless devices. These new technologies strongly affect the way people communicate, learn, train, think and solve their problems. Today, modern cell phones not only send and receive phone calls, but they also allow people to send and receive short messages, and e-mails, share photos and videos, write, edit and share documents, play games, listen to music, watch movies, surf the Internet, find an address using GPS (Global Positioning Systems) and use a wide range of applications. Given this consideration, excessive use of smartphones is associated with growing global concerns over the health effects of radiofrequency electromagnetic fields (RF-EMF) generated by these devices. As discussed by WHO, considering the very large number of people who use mobile phones, even a small increase in the risk of adverse health effects, either cancer or other health effects, could have key public health implications. WHO believes that research about these health effects is mostly focused on potential adverse effects of mobile phones, not their base stations, because the RF-EMF levels of mobile phones are 3 orders of magnitude higher than those of base stations. Therefore, in this chapter, due to the greater likelihood of adverse health effects of handsets, we mainly focused on reviewing the current scientific evidence on health risks associated with mobile phones. However, the health effects of RF-EMF exposure on people living in the proximity of mobile base stations are also reviewed.&nbsp;<br>]]></description> </item><item><title><![CDATA[Bioactive Compounds from Components of Marine Ecosystem]]></title><link>https://www.benthamscience.comchapter/20729</link><description><![CDATA[With the advent and rapid progress of the novel blue economy, the prospect of large-scale commercial production of diverse natural bioactive compounds from aquatic biota is likely to be realized in the near future. The biodiversity of the marine biota represents a potentially abundant source of new biomolecules with potentially different economical applications. Most of these biotas are able to survive under stress conditions, as a result, they produce complex metabolites with unique biological properties. These natural substances could be used as functional constituents in the food sector. Moreover, they could aid in the treatment of a broad range of different diseases, including antitumor, antioxidant, antiaging, anti-inflammatory, and antimicrobial. The special properties of these compounds make them an attractive group deserving increasing scientific interest. It is interesting to note that there are some biomolecules exclusively found in marine biota, including phlorotannins and sulfated polysaccharides. This chapter explains the bioactive molecules from different marine biota as well as illustrates their chemical structure and highlights their new biologically active form.<br>]]></description> </item><item><title><![CDATA[References]]></title><link>https://www.benthamscience.comchapter/20663</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Application of Main Group Elements and Their Compounds in Medicine]]></title><link>https://www.benthamscience.comchapter/20661</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Biological Functions of d- and f- Block Elements]]></title><link>https://www.benthamscience.comchapter/20660</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Medical Futility in Pediatrics: Challenges, Hopes, and New Perspectives]]></title><link>https://www.benthamscience.comchapter/20539</link><description><![CDATA[The concept of medical futility is explored, particularly in relation to the challenge of defining futile treatments, and the difficulties in identifying patient subgroups that strictly match the criteria for treatment futility. The issue of categorizing perinatal disorders as fatal is an important topic, with a focus on the moral and legal repercussions of identifying lethal malformation. The identification of a lethal malformation often has moral and legal repercussions, and the phrase “lethal” should be avoided unless it is precisely defined, used consistently, and covered in transparency in perinatal counseling following prenatal diagnosis. We argue that a nuanced and carefully considered approach is required, one that takes into account the complex medical and ethical issues involved, and that focuses on the best interests of the patient and their family. Overall, we highlight the importance of ethical considerations and effective communication in the provision of perinatal palliative care for fetuses with genetic disorders and congenital defects. Also, while there is much that remains uncertain and controversial in this field, continued research and discussions are necessary to ensure that the best possible care is provided for all patients and their families.<br>]]></description> </item><item><title><![CDATA[Introduction of Challenges with Pediatric Diseases]]></title><link>https://www.benthamscience.comchapter/20529</link><description><![CDATA[&nbsp;Children and the knowledge of taking care of them, pediatrics, are faced with growing challenges. With the advancement of medical sciences, pediatrics is becoming a group of subspecialties. This could lead to improving the care and management of pediatric disorders, however, transdisciplinary management should not be ignored. Although the health status of children has improved over the past years, still preventable child deaths are occurring, especially in low-income countries. The increased sexual abuse, discrimination, racism, increased intercountry adoption, malnutrition, environmental hazards like arsenic contamination, pornography, and surrogacy are among the most important current challenges to children’s health. Worldwide vaccination coverage has declined from 86% in 2019 to 83% in 2020, and the number of completely unvaccinated children increased by 3.4 million. Approximately, 1 billion children are dealing with multidimensional poverty all around the world among which at least 356 million of them live in extreme poverty, and 100 million more children plunged into poverty as a result of COVID-19. In this chapter, we will review the most important challenges of children’s health and pediatrics with a focus on social and mental health problems.<br>]]></description> </item><item><title><![CDATA[Reconnoitering Cell Factories of Marine Algae for Antimicrobials]]></title><link>https://www.benthamscience.comchapter/20459</link><description><![CDATA[Antimicrobial compounds are groups consistent with the microorganisms that they could potentially act against bacteria or fungi. It is expected to kill microorganisms or inhibit their growth and activity. As the case of antimicrobial resistance increases, nature has been generous in providing compounds with the potential to treat various ailments and infectious diseases. Bacteria, fungi and plants are known to own a good list of antibacterial molecules. Although research has been carried out to reveal the antimicrobial potential of natural products, the significance of vast terrestrial and marine Animalia has gained momentum. Though the naturally available antimicrobial agents obtained from plants, animals and microbial sources are considered safe in comparison with synthetic molecules, the outbreak of pathogens needs exploration over and above the reported ones. As the synthetic antimicrobials soon become immune to pathogens, it makes emphasis on antimicrobials from novel origins that have a long duration of effectiveness. The marine environment houses a wide and taxonomically diverse species of algae, mollusks, sponges, corals and tunicates. These organisms have adapted to survive the infectious environment by producing pharmacologically active compounds of phlorotannins, fatty acids, polysaccharides, peptides, and terpenes that help in battling bacterial annexation. As marine algae provide considerable opportunities in antimicrobials, the optimization in the methodologies leading to extraction and purification plays a greater role in capturing the antimicrobial activity of the bioactive molecules. Though an outsized number of potential antimicrobial compounds from marine algae have been identified and isolated, the majority of those compounds are yet to be categorized and commercialized. Recent research in algae focused on “omics” where metagenomics, metatranscriptomics and metaproteomics are done to understand better pathway leading to the synthesis of various functional molecules.<br>]]></description> </item><item><title><![CDATA[Immunomodulatory Plant Extracts and their Compounds. Evaluation of your Safety]]></title><link>https://www.benthamscience.comchapter/20386</link><description><![CDATA[Medicinal herbs have been in use for the management of human health, for prevention. as well as for the cure of human diseases since ancient civilizations. In recent times, the use of herbal drugs has increased in both developed and developing countries, because of the large chemical, pharmacological, and clinical knowledge of plant drugs and their derivatives, the development of new analytical methods for quality control, the development of new forms of preparation and administration of plant drugs and their derivatives and finally the relatively wide therapeutic margins with less frequent adverse effects. However, naturals are not a synonym for innocuous as many adverse effects can occur. In this regard, there are different levels of perceptions about the safety of medicinal herbs, varying from “completely safe” to “completely harmful”, although there is also a clear idea about its side effects depending on factors such as dosage, characteristics of the plant material and consumer-related factors. Because of this, medicinal plants need to be studied and effective and innocuous doses must be established. Nowadays, immunomodulatory drugs have gained a main role principally as a consequence of COVID-19 produced by the SARS-CoV-2 virus. Some South American plants frequently used in Argentine folk medicine such as Larrea divaricata and Ilex paraguariensis and others used all over the world like Tilia spp. and Coffeea Arabica are known to exert immune-enhancing effects. In this review, we discussed some reports about the immunological effect of the mentioned plants and their majority compounds, focusing on their efficacy and safety.<br>]]></description> </item><item><title><![CDATA[Subject Index]]></title><link>https://www.benthamscience.comchapter/20210</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Management of Children with Systemic Diseases]]></title><link>https://www.benthamscience.comchapter/20198</link><description><![CDATA[Significant oral problems are associated with many medical disorders. Close cooperation and consultation between the dentist and the child’s physician are essential to render optimum medical care. Prevention of oral disease is the primary consideration for these children. Medically compromised children can be challenging to treat and affect dental care [30]. To treat medically compromised patients safely, it is essential to Obtain a relevant and thorough medical history and understand the possible implications of the illness on dental treatment and the potential importance of the condition on treatment planning and the caries risk associated with the medical condition. With advances in medical treatment, significantly more children survive longer with more complex medical needs, and these children will present to the general dentist for dental treatment.<br>]]></description> </item><item><title><![CDATA[Drugs Used in Pediatric Dentistry]]></title><link>https://www.benthamscience.comchapter/20197</link><description><![CDATA[Children are in a state of delicate physiologic equilibrium and, unlike adults, are more susceptible to medications and their adverse effects. Medicines used for children should be carefully selected, and the minimum dose required should be administered. Possible adverse reaction in multidrug therapy is also essential. The pediatric dentist must also consider any other drug the child may be taking while prescribing drugs and understanding children’s presenting signs and symptoms.<br>]]></description> </item><item><title><![CDATA[Local Anesthesia in Pediatric Dentistry]]></title><link>https://www.benthamscience.comchapter/20194</link><description><![CDATA[Dental treatment has been associated with pain by adults and children alike. The fear associated with the perceived pain causes a lot of anxiety and is a common cause for patients to show avoidance towards basic dental care. A painless experience during dental treatment allows children to look forward to future dental appointments and allows the dentist to establish a good rapport with the child. Various agents are available for the administration of local anesthesia with lignocaine being the most common agent. As children have unique physiology and anatomic variations, the techniques for local anesthesia require minor modifications. Advances in local anesthesia materials and techniques have provided the dental surgeon to accomplish the goal of true painless dentistry.&nbsp;<br>]]></description> </item><item><title><![CDATA[Theranostics Inorganic Nano-particles for Brain Tumor Diagnosis and Treatment]]></title><link>https://www.benthamscience.comchapter/20168</link><description><![CDATA[Brain tumors pose a major threat to human health due to difficult treatment, rapid progression, and poor prognosis, resulting in a terrible fatality rate that has remained high over the years. As arteries have limited drug permeability into brain tumor tissue, the success rate of chemotherapy remains low. Considering the anatomic concerns of brain tumors and the interaction between the blood-brain barrier (BBB) and nano-particles (NPs), nanotechnology is deemed an attractive approach as it has the potential to increase brain drug distribution. Theranostic strategies have also been proposed in recent years and they are seen promising. NPs are considered ideal due to their size, ease of surface modification and, adaptability to integrating several functional components in one system. In lieu of this, the design of nano-particles with therapeutic and diagnostic uses has increased tremendously, particularly in cancer treatment. This two-pronged technique aids in understanding tumor tissue location, treatment progress, nanoparticle’s bio-distribution and, its efficacy as it is particularly valuable for personalized medicine-based treatments. In this chapter, we will focus on the properties of the blood-brain barrier and the blood-brain tumor barrier (BBTB), two important hurdles in brain-tumor targeted delivery, and the targeting strategies that aim at different stages of brain tumor growth and development as well as their recent advances in brain tumor-targeted novel nano-drug delivery systems.<br>]]></description> </item><item><title><![CDATA[Theranostics Micelles for Brain Tumor Diagnosis and Treatment]]></title><link>https://www.benthamscience.comchapter/20167</link><description><![CDATA[Brain cancer is considered one of the most vicious and devastating tumors owing to its poor prognosis and high mortality rate. Common strategies for treatment include surgery, radiation, and chemotherapy. Unfortunately, these are limited due to their invasive nature and the inherent difficulties of brain surgery, given there is a high possibility of tumor relapse. Further, radiation and chemotherapy have a non-selective harmful effect on normal tissues, accompanied by limited drug delivery due to the presence of various barriers, including the blood-brain barrier. For this reason, the theranostic approach was developed by incorporating one or more therapeutic and diagnostic agents in a single nanocarrier moiety which could be modulated at its surface with certain proteins, legend, surface markers, or a stimuli-responsive agent that is capable of selectively targeting the tumor site after passing through the blood-brain barrier. This new field will permit the early and precise detection of cancer tissue, facilitate the process of drug delivery and assist in monitoring treatment outcomes. Micelles are considered one of the most commonly used nanocarriers due to their high stability and loading capacity, along with efficient release controlling properties. This chapter will present brief information about brain anatomy and cancer, and will discuss the main strategies implemented in the diagnosis and treatment of brain cancers. Furthermore, it will introduce the theranostic micelle approach by highlighting micelles types and preparation techniques, as well as explain the different barriers and approaches to targeting.<br>]]></description> </item><item><title><![CDATA[Recent Development and Advancement in Microneedle-Assisted Drug Delivery System Used in the Treatment of Cancer]]></title><link>https://www.benthamscience.comchapter/20157</link><description><![CDATA[Cancer is one of the most common and distressing diseases. Cancer-related mortality and prevalence have both grown in the last 50 years. Due to its intricacy and progressive nature, cancer remains one of the most debilitating diseases in humans, and clinical care for this lethal disease remains a challenge in the twenty-first century. New and better cancer medicines are constantly needed. Due to the rising global incidence of cancer, the development of novel alternatives to traditional medicines is unavoidable to overcome constraints, such as limited efficacy, comorbidities and high cost. Microneedle arrays (MNs) have just been introduced as an innovative, low-cost, and minimally invasive technique. MNs can safely and precisely deliver micromolecular and macromolecular pharmaceuticals, as well as nanoparticles (NPs), to tumor tissue. However, only a few lipophilic pharmacological compounds with low molecular weight and a rational Log P value were able to pass the skin barrier. Microneedles (MNs) can circumvent these constraints by piercing the body's outermost skin layer and delivering a variety of medications into the dermal layer. MN patches have been made with a variety of materials and application methods. Recently, three-dimensional (3D) printing “A touch button approach” gives the prototyping and manufacturing methods the flexibility to produce the MN patches in a one-step manner with high levels of shape complexity and duplicability.&nbsp;<br>]]></description> </item><item><title><![CDATA[Nano-cosmetics and Nano-medicines]]></title><link>https://www.benthamscience.comchapter/20004</link><description><![CDATA[In today’s fast-moving scenario, nanotechnology has already spread its wings to nanocosmetics and nanomedicines due to the wide range of physical and chemical properties associated with nanoparticles. Different types of nanoparticles, like nanoliposomes, fullerenes, solid lipid nanoparticles etc., have made their entrance into the nanocosmetic industry. However, the safety concern of nanoparticles has forced the cosmetic industry to limit their applications. The pharmaceutical industry has explored the benefits of nanotechnology; it has developed dendrimers, micelles, drug conjugates, metallic nanoparticles etc. The brief explanation of these nanoparticles provides a salient glimpse of why they are used in nano pharmaceutical and medicinal chemistry. • Metallic nanoparticles: Used for drug delivery, cancer treatment, and also in biosensors. • Nano-liposomes: Bio-compatible and possess entrapment efficiency. • Nano-emulsions: Used for controlled delivery of bioactive materials.&nbsp;<br>]]></description> </item><item><title><![CDATA[Chromosome 16]]></title><link>https://www.benthamscience.comchapter/19979</link><description><![CDATA[Cancer is a heterogeneous disorder with invasive and metastatic potential. It is a deadly disorder affecting 1 in 6 people worldwide. Hence, it is important to eliminate the disease. Genetic alterations remain an underlying cause of cancer, and several gene mutations were involved in causing different types of cancer. Recently, researchers have been investigating the role of genetic mutations in causing cancer. For this reason, the genes associated with chromosome 16 were investigated for their role in causing cancer. This study revealed 70 genes associated with cancer. Of which, the cadherin genes (CDH11, CDH13, and CDH1), AXIN-1, ANKRD11, BANP, CYLD, CBFA2T3, IR8, MVP, MT1F, NQO1 and PYCARD was the tumor suppressor, and the gene MSLN is the potential oncogene. CBFB and MYH11 are well-known fusion genes associated with this chromosome. Loss of heterogeneity was noted in the q arm of this chromosome. The chromosome translocations, t (16;16) (16) (p13q22), t (16;21) (21) (p11;q22), t (12;16) (q13; p13; p11), t(16;21) (p11;q22) and t(7;16) (q33; p11) led to the development of acute myeloid leukemia, leukemia, and sarcoma. Several other genes associated with chromosome 16 responsible for cancer initiation and proliferation are summarized in this chapter. A novel insight into the genetic biomarkers and therapeutic targets has been provided to develop potential therapeutic strategies against cancer.&nbsp;<br>]]></description> </item><item><title><![CDATA[Overview of Cancer]]></title><link>https://www.benthamscience.comchapter/19884</link><description><![CDATA[The characteristics of cancer cells are continuous cell growth due to their non-responding nature to the signals of stopping the growth or apoptosis, the ability to spread in other parts of the body, and immortality of cells because of their capacity to restore their telomeres. The clinical features depend on the size and location of cancer and the presence or absence of metastasis. Local and systemic symptoms rely on the tumor mass and the body’s response to cancer, respectively. Cancer is classified according to the tissue involved, like Carcinomas, Sarcomas, Myeloma, Leukemia, Lymphoma, Germ cell tumor, and blastoma. The globally recognized standard to classify the extent of cancer spread is called T.N.M. Classification. It applies to many solid tumor cancers but is not relevant to leukemia and the central nervous systems tumor. The tumor can be diagnosed with tests like mammograms, Pap smears, Tumor markers, Bone scans, MRI, Tissue biopsies, and PET-CT scans. The treatment depends on the type and stage of cancer and the patient's overall health. Common treatment modalities are surgery, radiation, and chemotherapy. Other treatments are targeted/biological therapies, hematopoietic stem cell transplants, angiogenesis inhibitors, cryosurgery, and photodynamic therapy. Every treatment has its risks, benefits, and side effects.&nbsp;<br>]]></description> </item><item><title><![CDATA[Sphingolipid]]></title><link>https://www.benthamscience.comchapter/19855</link><description><![CDATA[Sphingolipids are a class of lipids containing the backbone of long-chain amino-alcohol bases in their structure, which are synthesized in the endoplasmic reticulum. Modification of this base gives rise to a variety of such lipids ranging from simple to complex sphingolipids that play a significant structural and functional role in membrane biology as well as regulate various cellular processes. Sphingosine, dihydrosphingosine and phytosphingosine are nature's most frequently occurring bases. Ceramides are the simplest sphingolipids after the backbone. These fatty acids are amide-linked derivatives of sphingoid bases and central intermediates of sphingolipid metabolism. Ceramides perform various biological functions and constitute the hydrophobic backbone of all complex sphingolipids. The best-characterized sphingolipids in fungi and yeast are glycosphingolipids (GSLs), which could be categorized into two groups, neutral GSLs (glucosyl and galactosylceramide) and acidic GSLs, (glycosylinositol-phosphorylceramides). Due to the several important functions of sphingolipids in cell biology, it is crucial to understand the regulation and metabolism of sphingolipids. Despite the diversity of structure and function of sphingolipids, their synthesis and degradation are governed by common synthetic and catabolic pathways. In recent years, significant progress in the field of sphingolipids has been made. Recent developments in sphingolipid biology, including the construction of analytical and genetic tools and the development of computer visualization techniques for sphingolipids analysis, have highlighted the role of sphingolipids in developing anticancer and antifungal therapeutics. Recent advances in sphingolipid biology continue to provoke and inspire vigorous investigations in sphingolipidology<br>]]></description> </item><item><title><![CDATA[Nanocollagen-graphene-antibiotic for Wound Healing]]></title><link>https://www.benthamscience.comchapter/19842</link><description><![CDATA[Nanotechnology is a greatly advancing field of scientific research due to its largely untapped potential, which may apply to various clinical uses. This book chapter focuses on the potential use of nanocollagen, graphene, and antibiotic components in biomaterial fabrication for wound healing. Nanocollagen is simply regular collagen broken down to the nanometer scale. Its nanocollagen-based biomaterials also conform to the ideals of tissue engineering, which are excellent biocompatibility with a high bioabsorption rate and little to no antigenicity while having an extensively cross-linked structure suitable for cellular growth and metabolism. Nanocollagen can be fabricated through electrospinning, nanolithography, self-assembly, and others. The physiology of wound healing follows specific proceedings, which are haemostasis, inflammation, and remodelling stages. The wound healing process may be improved through the use of nanocollagen biomaterials, together with the addition of graphene and antibiotics. Nanocollagen biomaterials aid in acting as a barrier for the wound against infections while providing collagen in the nanoscale to accelerate healing. The addition of antibiotics into the nanocollagen biomaterial aids in preventing bacterial infection by the inhibition of biofilm formation. Graphene, specifically in its oxide form, also acts as an antibacterial agent while potentially providing mechanical durability to the biomaterial scaffold. Along with the benefits of graphene oxide application in wound healing, its challenges are discussed in this book chapter. With that, this book chapter suggests the beneficial combinatorial factors of nanocollagen, graphene, and antibiotics that can potentially produce biomaterials with strong antibacterial properties while accelerating wound healing.<br>]]></description> </item><item><title><![CDATA[Nanobio-Inspired Materials for Tissue Engineering]]></title><link>https://www.benthamscience.comchapter/19837</link><description><![CDATA[The utilization of nanoscale biomaterials in various fields of modern science has shown great change and benefits in this present era. Due to their unlimited potential, many researchers have focused on further studies, and today, they play a good role in human health improvement programmes. Accordingly, it is true that the use of nanomaterials in tissue engineering is one of the most advanced technologies in medical care. The technology which integrates materials science and engineering with biology in order to improve the induction of tissue regeneration is called tissue engineering. This technology helps in controlling the cellular combined with synthetically engineered materials and is used for various treatments. One of its main functions is the treatment of structurally degenerated organs in the human body. Tissue engineering techniques can be upgraded with distinct properties of nanomaterials like better adaptability, good response, delivery potential, and better controllability. Moreover, unlike other materials, they are highly efficient, reliable, and easily decompose. Depending on the type of application, different kinds of nanomaterials are used, such as polymers, metals, ceramics, and their various compositions. Consequently, it can be assumed that the approaches of incorporating nanomaterials in tissue engineering will enhance the disciplines of tissue regeneration.<br>]]></description> </item><item><title><![CDATA[Destructive Effects of Steroidal Drug Abuse and their Immunological Impact]]></title><link>https://www.benthamscience.comchapter/19788</link><description><![CDATA[Steroidal drugs are synthetic in nature that are closely identical to naturally produced hormones in our body such as cortisol and testosterone. They are lifesavers for several threatening medical conditions. They are currently in wide use for the treatment of various inflammatory diseases since they are known to involve in suppressing the immune system resulting in a reduced inflammatory process. They are produced in different forms and do not cause any major side effects when consumed at low doses. However, occasionally they lead to perilous side effects when taken in appropriate doses that lead to mental health problems, high blood pressure, diabetes, osteoporosis, etc. Practices such as the uptake of illicit anabolic steroids and corticosteroid drugs without an appropriate prescription can potentially lead to fatal side effects. Anabolic steroids are performance and image-enhancing drugs that were once viewed as predicament associated with bodybuilders and have now become a widespread problem throughout our society including children. Dietary supplements which act as steroidal precursors also promote medical consequences that are similar to steroids and the absence of such awareness in our society leads to varied difficulties in our current lifestyle. The increasing concern about possible health hazards in association with abusive steroid drug uptake should be addressed with strict measures. It is important to educate our society about the hazardous effects of steroidal drug abuse and the precautions that need to be carried out while using them. This chapter highlights different types of steroid drugs that are currently in use and the deleterious side effects caused by their abusive use. Potential treatments for their withdrawal and preventive measures will also be addressed in detail.<u></u>&nbsp;<br>]]></description> </item><item><title><![CDATA[Immunological Significance of Steroids and Implications for Immune Related Diseases]]></title><link>https://www.benthamscience.comchapter/19785</link><description><![CDATA[This book chapter compiles a general idea of steroids and their overall biological significance in immunity and immune-associated diseases. Steroids chemically comprise a group of cyclical organic compounds constituted by seventeen carbon atoms that consist of four fused rings called sterane, and cyclopentanoperhydrophenanthrene. The four-ringed structures are mainly synthesized by mitochondria and smooth endoplasmic reticulum through the cyclization of thirty-carbon chain squalene into lanosterol or cycloartenol. Steroid hormones differ only in number of oxygen and carbon atoms, but all are derived from cholesterol. The biological significance of steroids and their derivatives range from energy metabolism, and body growth to the control of reproductive activities. However, deficiency or malfunctioning of steroids can lead to direct effects on body salt/sugar levels, sexual differentiation and immunity. As far as immune responses are concerned, a lot of research works have emerged which show the importance of steroids in immune regulation, and in extreme cases, they are also known to result in immune-related diseases. Most of these effects are mediated by the influence of steroids on gene expression in cells and this could in turn prove to be novel drug targets as well. We have made an attempt in this chapter to update and highlight the role of steroids in immune regulation and immune-related diseases, which we hope would open up therapeutic options for diseases.<br>]]></description> </item><item><title><![CDATA[Oxidative Stress and Leukocytes Activation - The Two Keystones of Ischemia/Reperfusion Injury during Myocardial Infarction, Valve Disease, and Atrial Fibrillation]]></title><link>https://www.benthamscience.comchapter/19768</link><description><![CDATA[Oxidative stress is a major contributor to ischaemia reperfusion injurymediated myocardial infarction. Coronary ischemia deprives the heart muscles of nutrients and oxygen in the areas away from the site of arterial blockage, rendering cardiomyocytes unable to utilise aerobic metabolism to support their energy requirements. Homeostatic intracellular signalling systems, such as the hypoxiainducible factor (HIF) transcription factor cascade, sense the low oxygen environment. This in turn stimulates the upregulation of numerous compensatory mechanisms which are ultimately involved in elevating anaerobic glycolysis and promoting angiogenesis and vascularization. The increased anaerobic metabolism increases the production of lactic acid hence metabolic acidosis. This leads to myocyte death and the expansion of the size of the original area of the infarct. Under normal aerobic conditions, the myocardium generally metabolises relatively high levels of adenosine triphosphates (ATP). In contrast, during ischemia, the shift in energy production to glycolysis results in the inefficient production of ATP and constitutes a pathological feature, and if not reversed early, it may lead to complications such as heart failure and ischemia-induced atrial or ventricular fibrillation. Despite the widespread use of fibrinolytic agents and new types of angioplasty procedures for the treatment of myocardial infarction, often new sets of complications persist. These include the occurrence of extensive tissue injury caused by myocardial reperfusion through the reintroduction of oxygen to the previous ischemic tissues because of the excessive generation of reactive oxygen species (ROSs) and depletion of antioxidants. Widespread production of ROS damages the plasma membrane and stimulates the release of various proinflammatory agents. Several proteins become denatured for example receptors, ionic channels, transporters, or components of transduction pathways through oxidation by ROS. Altered protein structure inhibits their functions leading to the disruption of vital cellular processes. The onset of reperfusion injury is further exacerbated by the activation and infiltration of the infarcted area by polymorphonuclear leukocytes (PMNs). Several studies have identified the release of different leukocyte intracellular factors during PMN activation such as selectins and b2-integrins to be related to the magnitude of tissue damage. Some studies have shown that antagonists for leukocytes intracellular factors such as selectins abrogate PMN activation and reduce the infarct size.<br><br>More recent publications have shown that PMN activation is closely linked to the activation of other cells involved in the inflammatory response. For example, during myocardial ischemia–reperfusion injury, it has been shown that the activity of neutrophils is also modulated by lymphocytes and macrophages. This chapter summarises the interaction between oxidative stress, activation of different leukocytes and the release of factors involved in the generation of reperfusion injury.<br>]]></description> </item><item><title><![CDATA[Plant Virus Nanoparticles and Their Applications]]></title><link>https://www.benthamscience.comchapter/19754</link><description><![CDATA[Plant virions, as nano-sized particles, have the advantages of high accumulation levels in plant cells, low regeneration cost, simple purification process and safety for the human body. They are ideal natural nanomaterials. With the development of bio-nanotechnology, plant virus nanoparticles show more and more applicable potential in the field of medicine. This chapter reviews the research progress and application of plant virus nanoparticles in the field of medicine, focusing on targeted drug delivery, molecular imaging and vaccine preparation.<br>]]></description> </item><item><title><![CDATA[Common Drugs Used in Dental Practice]]></title><link>https://www.benthamscience.comchapter/19731</link><description><![CDATA[The chapter provides an insight into the common drug therapy practiced in dental clinics for patients. Various routes of administration of drugs are explained. The responsibilities of the patient attendant are highlighted, which is very important and cannot be overlooked, considering the legal liabilities. Most of the important drugs are also described in this chapter.<br>]]></description> </item><item><title><![CDATA[Chromosome 5]]></title><link>https://www.benthamscience.comchapter/19704</link><description><![CDATA[Chromosome 5 presents an extensive collection of genes, and includes several cancer-associated ones. The contribution of chromosome 5 in abnormalities is evident through somatic translocations, germline, somatic, and, in some instances, expression of genes. Various syndromes are associated with chromosome 5, such as 5q minus syndrome, leading to the development of acute myeloid leukemia, PDGFRBassociated chronic eosinophilic leukemia contributing to acute myeloid leukemia, and myelodysplastic syndromes. Studies propose that a few genes on chromosome 5 play important roles withinside the increase and department of cells. When chromosome segments are deleted, as in a few instances of AML and MDS, those crucial genes are missing. Without those genes, cells can develop and divide too speedy and in an out-o- -control way. Researchers are trying to perceive the genes on chromosome five that might be associated with AML and MDS.<br>]]></description> </item><item><title><![CDATA[A Robust Model for Optimum Medical Image Contrast Enhancement and Tumor Screening]]></title><link>https://www.benthamscience.comchapter/19677</link><description><![CDATA[The use of medical imaging techniques have improved the correctness of disease screening and diagnosis. But, the quality of these images is greatly affected by real-time factors such as the type of machinery used, the position of a patient, the intensity of light, etc. The poorly maintained machines, incorrect positioning of patients, and inadequate intensity of light lead to low contrast and poor-quality medical images that work as hindrances in examining medical images. Thus, there is a need to upgrade the features of medical images. Researchers applied histogram equalization for contrast enhancement. However, it improves the visual appearance of medical images but faces the difficulties of over-enhancement, noise, and undesirable artifacts. Also, these techniques report low accuracy in tumor detection. Therefore, we propose an efficient model for medical image contrast enhancement and correct tumor prediction. The model performs segmentation, weighted distribution, gamma correction, and filtering to improve the visual appearance of MRI images. Further, it employs the optimum feature extraction for the correct detection of regions infected with tumors. Furthermore, findings obtained in a simulated environment demonstrate that our proposed model outperforms current models.<br>]]></description> </item><item><title><![CDATA[Anti-trypanosomatid Drugs/Candidates in Clinical Trials: What's New and What's Missing?]]></title><link>https://www.benthamscience.comchapter/19610</link><description><![CDATA[Parasites and infectious agents are responsible for neglected tropical diseases (NTDs) that affect many countries worldwide. At least one NTD is found 149 countries, mostly in low-income countries with poor sanitation, and it impacts over a billion people. According to the World Health Organization, trypanosomiasis is a group of protozoan infections that cause Chagas disease (Trypanosoma cruzi), Human African Trypanosomiasis (sleeping sickness - <i>Trypanosoma brucei</i> rhodesiense or <i>Trypanosoma brucei</i> gambiense), and <i>Leishmaniasis</i> (<i>Leishmania</i> spp. - Trypanosomatidae family), which are all considered NTDs. It is estimated that approximately 500,000 deaths from NTD infections occur annually worldwide. Despite the many cases associated with NTDs, treatments for most of these diseases are available. However, they are associated with significant adverse effects and a growing number of drug-resistant microorganisms and require parenteral administration. Besides that, many trypanosomatid diseases are zoonotic, making eradication extremely difficult. In this way, despite scientific progress over the years, some drug discovery goals remain unmet, such as the development of new therapeutic classes, reduced toxicity, improved administration regimens, or the development of combination therapies. Therefore, this chapter intends to present the six categories of drugs,<i> i.e</i>., the currently used therapeutic agents, nitroaromatic compounds, azole antifungal, benzoxaboroles, nitrogen heterocycles, and miscellaneous agents in clinical trials for NTDs, focusing on infections caused by trypanosomatids. In addition, the review approach presents the development process of the new drugs or treatment regimens in Phase I, II, III, and IV studies of the clinical trials based on the Drugs for Neglected Diseases initiative (DNDi) portfolio published in December 2020.<br>]]></description> </item><item><title><![CDATA[Probiotics as Potential Remedy for Restoration of Gut Microbiome and Mitigation of Polycystic Ovarian Syndrome]]></title><link>https://www.benthamscience.comchapter/19569</link><description><![CDATA[Polycystic ovarian syndrome (PCOS) is the most frequent endocrine disorder currently plaguing women. There are many factors associated with high androgenicity in the female body. Dysbiosis of gut microbiota may be one of the primary reasons that initiate PCOS. Emerging evidence suggests that some plastics, pesticides, synthetic fertilizers, electronic waste, food additives, and artificial hormones that release endocrine-disrupting chemicals (EDCs) cause microbial Dysbiosis. It is reported that the permeability of the gut is increased due to an increase of some Gram-negative bacteria. It helps to promote the lipopolysaccharides (LPS) from the gut lumen to enter the systemic circulation resulting in inflammation. Due to inflammation, insulin receptors' impaired activity may result in insulin resistance (IR), which could be a possible pathogenic factor in PCOS development. Good bacteria produce short-chain fatty acids (SCFAs), and these SCFAs have been reported to increase the development of Mucin-2 (MUC-2) mucin in colonic mucosal cells and prevent the passage of bacteria. Probiotic supplementation for PCOS patients enhances many biochemical pathways with beneficial effects on changing the colonic bacterial balance. This way of applying probiotics in the modulation of the gut microbiome could be a potential therapy for PCOS.<br>]]></description> </item><item><title><![CDATA[Bioremediation of Pharmaceutical Waste]]></title><link>https://www.benthamscience.comchapter/19547</link><description><![CDATA[Industrial production of pharmaceutical products is rising simultaneously with the increase in the world population and urbanization. They are vital in the treatment, prevention and control of diseases. Although pharmaceutical products play a pivotal role worldwide, their disposal and subsequent toxic metabolites are causing havoc in the environment. Accumulation of these hazardous pollutants in the environment increases the chances of reaching and affecting communities. The potential toxicity of these compounds includes the ability to be mutagens, carcinogens and genotoxins. Remediation methods currently available to rejuvenate nature from such wastes are generally expensive and may convert one toxin to another. Therefore, the use of microorganisms for the bioremediation of pharmaceutical and toxic waste has become an economical and effective alternative. Bioremediation techniques further detoxify the waste into useful or harmless products that can be beneficial to the ecosystem<br>]]></description> </item><item><title><![CDATA[Subject Index]]></title><link>https://www.benthamscience.comchapter/19498</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Still Birth]]></title><link>https://www.benthamscience.comchapter/19497</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Urogenital Abnormalities]]></title><link>https://www.benthamscience.comchapter/19490</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Abnormalities of the Central Nervous System]]></title><link>https://www.benthamscience.comchapter/19485</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Subject Index]]></title><link>https://www.benthamscience.comchapter/19429</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Alkaloids: A Brief Overview of Botanical and Pharmacological Properties]]></title><link>https://www.benthamscience.comchapter/19422</link><description><![CDATA[The classical definition of alkaloids describes this class of secondary metabolites as chemical structures containing nitrogen as part of a heterocyclic, with alkaline character, characterized by complex structure and limited distribution, mainly in the plant kingdom. The modern history of alkaloids starts in the early nineteenth century as figured by two milestone dates, 1803 when Derosne described the isolation of a mixture containing narcotin and morphine from opium, and 1819 when the chemist Meissner delivered an operative definition of the term alkaloid. They have been observed with sporadic distribution in bacteria, fungi, Pteridophytae and Gymnophytae, while they are mainly represented in higher plants and within Angiosperms, particularly in selected families, such as Annonaceae, Lauraceae, Loganaceae, Menispermaceae, Papaveraceae, Ranuncolaceae, Rubiaceae, Rutaceae, Solanaceae and others. Frequently, a plant activates selectively a metabolic pathway that produces a mixture of multiple but structure-related alkaloids. Sometimes, dozens may be with a restricted number representing the majority of the total content. The latter parameter could change significantly as a result of a plethora of many factors, including the plant organ, seasonal variations, phenological status and others. As general rules, the alkaloids are segregated in the form of salt inside cell vacuole or sometimes in laticifer, mainly through the superficial tissues, supporting the hypothesis of their biological involvement in plant-environment interactions.&nbsp;<br>]]></description> </item><item><title><![CDATA[Advances in Nanopharmacology: Focus on Reproduction, Endocrinology, Developmental Alterations, and Next Generational Effects]]></title><link>https://www.benthamscience.comchapter/19347</link><description><![CDATA[To date, the application of a wide range of nanostructured materials (NSMs), such as carbon nanotubes, silica compounds, metallic nanoparticles, nanovesicles (liposomes and exosomes), nanohydrogels (NHGs), nanohydroxyapatite (NHAPs), chitosans, and graphenes, has gained interest for various applications in biomedical sciences. These nanoparticles presented outstanding biological and mechanical features. Although the biocompatibility of NSMs is highly investigated, their interaction with the reproductive system is less exploited. On the other hand, recently, NSMs-mediated drug delivery presents a competent method in reproduction biology. Emerging evidence from the literature supports the considerable progress in nanopharmacology, which has transformed the theory of targeted biological delivery, permitting the engineering of complex biocompatible organic/inorganic platforms with a vast loading capacity, highly selective affinity, stability, and capacity for multiple, simultaneous usages; all within the nanometer scale. In this chapter, first, the potential application of NSMs in the field of reproduction is highlighted. Then, the possible effects of these materials on reproduction, endocrinology, developmental alterations, and next-generation impact will be discussed. The data presented in this chapter could provide insight into the effect of NSMs on the reproductive system and development and lead to better risk assessment of these materials or synthesis of safe nano-drug delivery systems to the reproductive organs.<br>]]></description> </item><item><title><![CDATA[Advances in Cardiovascular Nanopharmacology]]></title><link>https://www.benthamscience.comchapter/19344</link><description><![CDATA[Nanotechnology has caused the most noteworthy influence on oncology, recently. Many nano-based delivery systems for specific medicines and a diversity of other diseases are being advanced nowadays. Nanomedicine is preferably adapted to resolving the main issues of numerous diseases, as it offers the special opportunity to create specific nanoparticles as a carrier for the targeted and controlled transferal of several therapeutic agents to the targeted location. Moreover, ligand-targeting or receptor-mediated targeting methods relate to an extra degree of complexity that may be implemented in the nanoparticles-based product in cardiovascular diseases. Despite the noteworthy increase in studies on the use of nanoparticles in cardiovascular disease, some reports have shown that different types of nanoparticles have cytotoxic action. Future studies are desired to fully investigate toxicity, especially cytotoxicity and inflammatory responses for nanomaterials. The outline of new plans to reduce toxicity should be the aim of future studies. In the present chapter, we emphasize new developments in cardiovascular nanopharmacology and the assistant methods for scheming new nanomaterials for this field. The future lookouts have also been discussed.<br>]]></description> </item><item><title><![CDATA[Computational and Theoretical Techniques in Biomedicine]]></title><link>https://www.benthamscience.comchapter/19335</link><description><![CDATA[&nbsp;Biomedicine research has gained momentum for the development of various computational and theoretical techniques. Researchers working in biomedicine and bioinformatics depend on computational intelligence and its widespread applications. New algorithms have been described that enable computational simulations and mathematical modelling in coordination with analytical methods to comprehensively study biological systems. Many algorithms, such as Artificial Neural Networks (ANNs), Rough Sets (RS), Fuzzy Sets (FS), Particle Swarm Optimization (PSO), Evolutionary Algorithm (EA), etc., allow reliable and accurate analysis of vast data sets in biomedicine. Computational techniques analyse gene expression data obtained from microarray experiments, predict protein-protein interactions, model the human body in disease conditions, such as Alzheimer’s disease or cancer, follow the progression of the diseases, classify tumours, analyse which genotype responds to certain drugs, etc. Multiscale modelling of the human body in various disease conditions is a topic of interest in this context. Relevantly, the “Virtual Human” project has initiated the study of human organs and systems in disease conditions based on computational modelling. Therefore, many computational and theoretical techniques have been developed for intelligent information processing to lead an expansion in biomedicine research.&nbsp;<br>]]></description> </item><item><title><![CDATA[Green Economy with Blockchain and Microgrid]]></title><link>https://www.benthamscience.comchapter/19266</link><description><![CDATA[100 % Green economy is a dream to be realized by every economy in the world. Every economy is firm in its motives in terms of investing in Green Technology and enhancing its contribution to the Green Economy, strategically any nation that masters the art of maximizing its Green Energy productivity is going to be a crucial player in the world order. In this scenario, Blockchain comes in as a tool that can be positively exploited for mankind’s betterment, especially in the field of Energy Conservation. Microgrid system in this context is a revolutionary mechanism for opening up the market of energy exchange to the public and reducing energy wastage/consumption.<br>]]></description> </item><item><title><![CDATA[Diseases and Disorders Associated with Immune System]]></title><link>https://www.benthamscience.comchapter/19249</link><description><![CDATA[The human immune system is one of the complex systems of the body, which works against both external and internal invasion. It has two parts: the innate and the acquired immune systems. We have been born with the innate system which gives a quick response for the invading pathogen non-specifically. To deal with the typical environmental antigens, immune system adapts to changes. The acquired (or adaptive) component develops over time and produces antibodies that “remember” invaders to fight them if they return. Failure of it could be due to genetic defect (weak natural immunity), inability to adapt to the change, hyper-responsiveness, or inability to distinguish self from foreign, leading to various diseases and disorders. Various genetic defects of the immune system are at the core of Primary Immune disorders (PIDs), while overactivity is responsible for allergic diseases. Autoimmune diseases are mostly due to malfunction of the adaptive immune system, while in Systemic Autoinflammatory Disorders (SAIDs), the innate immune system is affected. Advancements in technology and genetics have improved our understanding of the pathogenesis, diagnosis, and management of these diseases.<br>]]></description> </item><item><title><![CDATA[Introduction: Immune System & Modulation of Immune System]]></title><link>https://www.benthamscience.comchapter/19248</link><description><![CDATA[The immune system is a complex, intricate organ system with features like flexibility, recognition, discriminating potential between self from non-self, and memory to defeat notorious external and internal threats to human health functioning. Innate immunity is inborn, and acquired immunity develops through secondary education; they are interconnected, interdependent, and execute tasks with bidirectional communications. A deeper understanding of immune biology revealed a remarkable contribution of the immune system in several chronic illnesses, and has taken a central stage in pathophysiology. In essence, the weakened or overactivated immune system leads to these chronic illnesses. Modulation of the immune system is an efficient and valid approach to prevent the underlying pathophysiology of such diseases. A gamut of natural immunomodulators targeted at specific or non-specif immune cells has delineated their potential to achieve the equilibrated and balanced immune system. Preclinical and clinical studies demonstrated the implication of microbiota, nutrients, natural herbs, and micronutrients for immunostasis. The immune system's complexity, its close association with the endocrine and nervous system, target identification, and convenient, reliable tools to assess immune function and modulation are a few limitations that hampered the attainment of immunostasis. Despite these limitations, novel therapies targeted at immunomodulation in chronic diseases are promising and paving the future path to novel therapeutics.<br>]]></description> </item><item><title><![CDATA[West Nile Virus and Toll-like Receptors]]></title><link>https://www.benthamscience.comchapter/19171</link><description><![CDATA[West Nile Fever is transmitted by West Nile Virus (WNV), which is a single-stranded RNS flavivirus. This disease is transmitted by the bite of mosquitoes. This disease is endemic in various countries in Africa, Asia, Europe and North America [1, 2]. There is no vaccine yet for this disease which is displayed by various symptoms in humans varying from neurological squealae (encephalitis) and meningitis. Apart from this, patients report fever, headache, and myalgia as well.<br>]]></description> </item><item><title><![CDATA[Chikungunya Virus and Toll like Receptors]]></title><link>https://www.benthamscience.comchapter/19170</link><description><![CDATA[Infected mosquitoes of Aedes species spread Chikungunya fever upon the biting of the mosquitoes. Chikungunya fever first came to the limelight upon an outbreak in southern Tanzania in 1952. These days almost all countries in the world are reporting Chikungunya fever. There is no vaccine for the Chikungunya virus. The infection causes severe joint pain, nausea, vomiting, conductivities, headache, and muscle pain, followed by fever. Clinical manifestations occur after 2-7 days of the mosquito bite. This chapter addresses key issues on Chikungunya viral infection in brain cells with reference to the triggering of events associated with toll-like receptors.<br>]]></description> </item><item><title><![CDATA[Introduction to Vector Borne Diseases]]></title><link>https://www.benthamscience.comchapter/19164</link><description><![CDATA[Vector-borne diseases(VBDs) are reported to represent amount 17% of all infectious diseases. The geographical distribution of vectors depends upon various climatic factors, and social factors. In the recent past, the spread of VBDs across the world is so rapid that it is associated with a change in climatic factors, global warming, travel and trade, unplanned urbanization, deforestation etc. Amongst the vector-borne diseases notable is West Nile fever (WNF) caused by West Nile Virus (WNV). WNF belongs to the family of Flaviviridae, which is part of the Japanese encephalitis antigenic group. WNV is transmitted from infected birds to human beings by mosquito bites. WNV is readily reported in Africa, Europe, the Middle East, North America and West Asia. Looking at the history, WNV was first isolated in a woman in the West Nile district of Uganda in 1937. It was identified in birds (crows and columbiformes) in the Nile delta region in 1953. Over the past 50 years, human cases of WNV have been reported in various countries.<br>]]></description> </item><item><title><![CDATA[Cancer Surveillance]]></title><link>https://www.benthamscience.comchapter/19131</link><description><![CDATA[Surveillance against tumors is governed by both intrinsic (non-immune) and extrinsic (immune) surveillance. While research on non-immune surveillance started as early as the 1960s when it was demonstrated that cell environment within and around can induce tumor-suppressing mechanisms, a major part of the progress is missing compared to immune surveillance. Part of the reason could be due to the fact that immune surveillance is seen to have more potential in therapeutic application in curing cancerous tumors compared to non-immune surveillance mechanisms. Many of the non-immune mechanisms are still under investigation as theories, although a few studies have shown their possibility. Contrary to this, there is a plethora of studies on immune surveillance. The immune system has been proven to have a role in the surveillance against tumors, thus conferring a certain degree of protection. However, not all tumor cells are successfully detected by innate immunity, and many of them have developed strategic ways of escaping adaptive immunity. The immunosurveillance in both animal models and humans shows overwhelmingly that cells with immunodeficiencies are more susceptible to tumor development. However, it is confounding that even immune-competent individuals develop tumors, and thus a significant process is responsible. Thus, immunoediting was proposed as a theory to explain why tumors can escape immunosurveillance. This chapter provides detailed evidence from animal and human tumors and analyses the mechanisms, pathways, and components implicated in tumor immune surveillance. The findings suggest that while immune surveillance could be the key to promoting immune function against the development of tumors, there is more research and understanding needed in the various mechanisms and cells implicated. This is because most, if not all, of the therapeutic studies using immune effectors have proved to be poor in preventing, treating, or regulating the development of tumors.<br>]]></description> </item><item><title><![CDATA[Immunotherapy and Cancer Stem Cells]]></title><link>https://www.benthamscience.comchapter/19129</link><description><![CDATA[Immunotherapy is one of the important modalities in the treatment of cancer since it can directly target the tumor and its microenvironment with lesser side effects and cytotoxicity. The main goal of immunotherapy in the treatment of cancer is the reactivation of the immune system against cancer cells. In this way, the body fights against cancer using its immune system rather than relying on external agents which might be harmful to other healthy parts of the body. The development of monoclonal antibodies (Mabs) has delivered a significant therapeutic effect. Mab therapy is one of the most evolving techniques in cancer immunotherapy and has shown efficacy in controlling several types of malignancies. There are several other methods by which the activation of the immune system can be achieved, such as by using small molecules or by targeting ligands. Interestingly, studies have demonstrated that cancer stem cells have also been found as a target for effective immunotherapy. Additionally, the complete elimination of the cancer cells requires longer sustainability of tumor-specific T cells. Primitive results suggest that these T cells can be localized to tumor cells, mediating highly effective immunotherapy. However, despite these huge successes, several problems still persist and must be overcome. This chapter discusses the current and cutting-edge immunotherapeutic approaches to fight against cancer cells.<br>]]></description> </item><item><title><![CDATA[Treatment of Cancer]]></title><link>https://www.benthamscience.comchapter/19128</link><description><![CDATA[Surgery, the oldest cancer treatment, is a mainstay in the cure and control of most cancers. Indeed, for many patients, surgery, usually in combination with chemotherapy, is the only hope for long-term survival or cure. But surgery can do more than treat cancer; it can also diagnose cancer (diagnostic surgery), investigate cancer further (staging surgery), debulk tumors (debulking surgery), relieve pain (palliative surgery), prevent cancer from occurring in the first place (preventative surgery), restore the appearance or function of the body after cancer surgery (reconstructive surgery) and help medical staff to administer chemotherapy (access surgery). This chapter looks at each of these purposes of cancer surgery in detail.&nbsp;<br>]]></description> </item><item><title><![CDATA[Growth Factors and Cancer]]></title><link>https://www.benthamscience.comchapter/19118</link><description><![CDATA[Cancer causes major patient morbidity and mortality and is a critical health concern worldwide. The recent GLOBOCAN 2019 factsheet recorded nearly 19.2 million new cancer cases, 9.9 million cancer deaths and 50.55 million people suffering from different kinds of cancer globally within 5 years after diagnosis. Growth factors (GF) are a group of proteins that can affect cellular processes, including differentiation, division, intravasation, extravasation and dissemination. The circulating tumor cells in the bloodstream can populate distant tissues and organs and believe to be the primary cause of metastasis. Extravasation is a crucial phase in the metastasis process, in which tumor cells leave the bloodstream and enter the host tissue. The progress of metastasis is triggered by the tendency of cancer cells to disseminate to target organs from the site of the primary tumor. Despite extensive basic scientific and clinical investigations, cancer is still a major clinical and public health problem. The development of cancer can be influenced by genetics, environmental factors, gene-environment interaction, lifestyle, age and a number of other factors. The harnessing and enhancement of the body’s own cytotoxic cells to prevent basement membrane rupture and the intervening dissemination processes can provide useful insight into the development of cancer. The mutation in oncogenes and tumour suppressor genes, and chromosomal aberration is a cornerstones of the molecular basis of cancer. The basement Membrane (BM) acts as a cell invasion shield, thus identification of processes that underlie in breaching of BM can contribute to understanding the disease pathogenesis. TGF-β is known for its dual function; it requires inhibition in the advanced stage however, the growth inhibitory properties are displayed in the early stages of tumorigenesis. Therefore, inhibition of TGF-β signalling in the CD8+ T cell compartment may be necessary for tumor immunity to be restored. Quantitation of tumour cell dissemination is important and plays significant role in elucidating mechanisms of cancer and strategies for therapeutic intervention.&nbsp;<br>]]></description> </item><item><title><![CDATA[Exogenous Factors and Cancer]]></title><link>https://www.benthamscience.comchapter/19116</link><description><![CDATA[The causation of cancer, whether exogenous or endogenous, is a cornerstone of cancer prevention and treatment. Many intrinsic factors are discussed in other chapters of this book; this chapter will shed light on exogenous factors influencing cancer with detailed specific examples of microbial, physical and chemical factors. Microbial role in cancer has been debated over many centuries, whether as an antagonist or a cause, since Imhotep’s time through the mid-17th century when cancer was considered contagious, and later cancer hospitals were forcefully moved out of the cities as isolation camps. There are now vivid evidences that specific microbial pathogens are causing up to 25% of cancer cases (lymphoma, solid or others), and in some cases, a single pathogen was found in association with many types of cancer, such as HPV and EBV, to a lesser extent. Also, several non-biological factors are classified as carcinogens as humans are exposed to millions of chemicals whether in environment or smoke processed food.<br>]]></description> </item><item><title><![CDATA[Repurposed Drugs/Potential Pharmacological Agents Targeting Cytokine Release and Induction of Coagulation in COVID-19]]></title><link>https://www.benthamscience.comchapter/19057</link><description><![CDATA[Global public health has been challenged by the coronavirus 2019 (COVID- 19) and has been a threat to clinical management to fight this viral infection. Due to the lack of specific therapies, there is a race among the scientific fraternity to find its specific cure to date. COVID-19 symptoms range from mild fatigue to potentially fatal pneumonia, cytokine storm (CS), and multi-organ failure. Hence, investigating the repurposing of current medications for use in the management of COVID-19 patients is a realistic approach. It is prudent to investigate using repurposed medications in the management of COVID-19 patients. In the meantime, researchers are testing a number of antiviral and immunomodulatory medicines to combat the infection. Although antiviral as well as supportive medications are undoubtedly vital in the treatment of COVID-19 patients, anti-inflammatory agents play an essential part in COVID-19 patient care due to their potential to prevent additional injury and organ damage and/or failure. Moreover, COVID-19-mediated infection can be linked with coagulopathy. The most common thrombotic events in COVID-19 are venous thromboembolic (VTE), which are linked with increased severity of disease and poor clinical outcomes. Here, we evaluated medicines that potentially modulate pro-inflammatory cytokines and assist in COVID-19 management. We emphasized various pro-inflammatory cytokines as targets of repurposed drugs and targeted induction coagulation in COVID- 19 patients using the available literature and studies.<br>]]></description> </item><item><title><![CDATA[Repurposed Drugs Against SARS-CoV-2 Replication in COVID-19]]></title><link>https://www.benthamscience.comchapter/19055</link><description><![CDATA[COVID-19 caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV -2), has emerged as a global health problem. It was first reported in Wuhan city of China, in December 2019. Unfortunately, no specific and effective drug is available to treat SARS-CoV-2 infection in patients. There is an urgent need to control COVID-19pandemic. Research &amp; development of novel molecules is a timeconsuming and labour-intensive procedure in the midst of a pandemic. The aim of drug repurposing is to find a therapeutically effective molecule from a library of pre-existing compounds. In the present article, a large number of anti-viral drugs with their potential efficacy in inhibiting replication of virus by targeting the virus S protein (Spike protein), 3-chymotrypsin-like protease (3CLpro), RNA-dependent RNA polymerase (RdRp) and papain-like protease (PLpro), which play an important role in the replication cycle and pathogenesis of coronaviruses, were assessed as possible treatment options against SARS-CoV-2 infected COVID-19 patients. The continuing SARS-CoV-2 epidemic emphasises the importance of efficient anti-viral medications that can be administered swiftly to decrease morbidity, death, and viral transmission. Several breakthroughs in the development of COVID-19 treatment options might be made by repurposing widely active anti-viral medicines and chemicals that are known to suppress viral replication of related viruses.<br>]]></description> </item><item><title><![CDATA[Taurine and the Liver: A Focus on Mitochondria-related Liver Disease]]></title><link>https://www.benthamscience.comchapter/18976</link><description><![CDATA[&nbsp;Although the liver is the leading site for taurine (TAU) synthesis, the level of this amino acid in hepatic tissue is relatively low. It is well-known that TAU is efficiently redistributed from hepatocytes to the circulation. However, the human body’s capacity for TAU synthesis is negligible, and we receive a very high percentage of our body TAU from exogenous sources. Plasma TAU is taken up by several tissues, such as the skeletal muscle and the heart. The roles of TAU in liver function are the subject of many investigations. It has been found that TAU could have beneficial effects against xenobiotics-induced liver injury, alcoholism-associated hepatic damage, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), or even viral hepatitis infections. The inhibition of cytochrome P450, alleviation of oxidative stress, inhibition of inflammatory reactions, and the mitigation of tissue fibrosis are fundamental mechanisms proposed for the hepatoprotective properties of TAU. On the other hand, many studies indicate that hepatocytes’ mitochondria are essential targets for the cytoprotective properties of TAU. The current chapter reviews the beneficial role of TAU on the most common liver disorders, focusing on the effects of this amino acid on mitochondrial function and energy metabolism.<br>]]></description> </item><item><title><![CDATA[Diabesity and the Kidney]]></title><link>https://www.benthamscience.comchapter/18814</link><description><![CDATA[Diabetes Mellitus and obesity, now coined as “Diabesity”, is a worldwide epidemic that imposes a huge burden on healthcare and society. Diabesity has been associated with poor outcomes and increased morbidity and mortality. The kidneys are a vulnerable target of diabesity. In this chapter, we discuss the epidemiology, pathophysiology, and treatment of diabesity–induced kidney disease. We specifically focus on the therapeutic targets and pharmacological management of diabesity-related kidney diseases.&nbsp;<br>]]></description> </item><item><title><![CDATA[Current Strategies of New Drugs for Diabetes Management]]></title><link>https://www.benthamscience.comchapter/18810</link><description><![CDATA[Several aspects need to be explored in drug therapy for diabetes patients. Some specific glucose-reducing medicines are present, while other medicines are associated with unintentional changes in hyperglycemia. Diabetes is a developing epidemic that has caused significant socioeconomic problems in several countries throughout the world. Despite scientific discoveries, greater healthcare services, and higher literacy rates, the disease continues to plague many industries, particularly developing countries. The current trends show an increase in premature mortality, which threatens world prosperity. Experimental and technical improvements have been made in sulphonylureas, alpha-glucosidase inhibitors, biguanides, and thiazolidinediones, all of which are beneficial in lowering glucose levels. The latest drug research techniques have led to the development of novel therapeutic groups such as amylin analogs, incretin mimetics, GIP analogs, active peroxisome proliferator receptors, and dipeptidyl peptidase-4 inhibitors as targets for future diabetes therapy medications. Furthermore, drug development and detection for diabetes treatment have been revolutionized by identifying and investigating bioactive compounds from herbs. This chapter discusses vital fields of clinical diabetology regarding opportunities for stem cells and nanotechnology as next-generation therapies, with an emphasis on evolving developments and reviews why plant-derived products are reliably common for treating and managing diabetes.&nbsp;<br>]]></description> </item><item><title><![CDATA[Neuroprotective Effects of Berberine in Neurodegenerative and Neuropsychiatric Disorders]]></title><link>https://www.benthamscience.comchapter/18780</link><description><![CDATA[Berberine is an isoquinoline alkaloid obtained naturally from the roots, rhizomes, and bark of various plant species, such as Berberis, Phellodendron, etc. It is an integral part of various medical systems, such as Ayurveda, Chinese traditional medicine, and Yunani medicine. It possesses various properties, such as anti-diabetic and anti-obesity properties, controls lipid profile, and is a strong antioxidant that helps in protecting against oxidative stress. It acts on multiple pathways throughout the brain and periphery to exert a wide variety of effects that can be beneficial for human use. Berberine is effective in protecting against neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and ischemia, and it also protects against neuropsychiatric disorders, such as schizophrenia, mania, anxiety, and depression. It is a potent PI3K/Akt pathway activator, decreases proinflammatory cytokine production, reduces glutamate excitotoxicity, triggers the synthesis of neurotrophic factors, increases levels of biogenic monoamines, such as serotonin, dopamine, and norepinephrine, and shows anxiolytic effects by modulating GABA levels. In this chapter, we discuss how berberine mediates these effects, modulates which pathways in the brain and body, and how does it provide a wide array of responses.<br>]]></description> </item><item><title><![CDATA[Bacopa monnieri and Neural Health: An Indian Herb]]></title><link>https://www.benthamscience.comchapter/18777</link><description><![CDATA[The disorders of the central nervous system are increasingly recognized as one of the most prevalent disorders in the present world. It has been envisaged that neurological disorders will be of great concern in the present and future populations worldwide. The different neurological disorders may be associated with signs, such as loss of memory, impaired brain function, cognitive deficits, etc. The occurrence of such degenerative diseases of the nervous system certainly imposes medical and public health burdens on populations worldwide. The multifactorial nature of such neural disorders entails the use of modern medicine in combination with conventional medicines for treatment. There has been undeniably a revolution in the foundation of existing medical facilities, which have been strengthened by the amalgamation of phytomedicine. In recent times, the use of medicinal herbs to improve mental function has come into the limelight in both developed and developing countries. Increased research is being carried out to discover Ayurvedic medications owing to their biosafety profile and utility in cognitive impairment. The current chapter deals with the depiction of one such plant, that is Bacopa monnieri, which possesses neuroprotective properties, and is considered to be Medhya Rasayana (a nootropic drug). This Indian herb, being a dietary anti-oxidant, has several modes of action to protect the brain against oxidative damage and age-related issues. A majority of the plant compounds, such as polyphenols, alkaloids, and terpenes, present in medicinal plants, have been known to have therapeutic properties against neurodegeneration mainly by virtue of their antioxidant, anti-inflammatory, and anti-amyloidogenic effects.&nbsp;<br>]]></description> </item><item><title><![CDATA[Tinospora cordifolia in Neurodegeneration: A Strong Antioxidant and Anti-inflammatory Phytotherapeutic Drug Candidate]]></title><link>https://www.benthamscience.comchapter/18775</link><description><![CDATA[Tinospora cordifolia is a Rasayana herb of Ayurveda, commonly known as “Heavenly Elixir” or “Amrita”, and one of the most exploited herbs in herbal medicines. T. cordifolia is well reported for its various pharmacological properties, such as anti-diabetic, anti-inflammatory, antipyretic, immunomodulatory, anti-cancer, cardioprotective, neuroprotective, and hepatoprotective activities. The prevalence of neurodegenerative diseases and other neurologic disorders is increasing worldwide. Oxidative stress and neuroinflammation are among the major pathologic mechanisms underlying neurodegenerative diseases. This chapter discusses the pieces of scientific evidence of the beneficial effects of T. cordifolia in various brain-related ailments. Various research groups have demonstrated the ability of T. cordifolia and its extracts to normalize oxidative stress and suppress the inflammatory response against various causative agents, and thus suggested that T. cordifolia has the potential to be a neurotherapeutic drug candidate in the future.<br>]]></description> </item><item><title><![CDATA[Beyond the Synthetic Drugs: Fungal Endophytes Derived Bioactive Compounds in the Management of Neurodegenerative Disorders]]></title><link>https://www.benthamscience.comchapter/18773</link><description><![CDATA[Fungal endophytes are a group of fungi that reside in plant tissues and show a symbiotic relationship with the host plants. They protect against pathogens and increase food availability without causing any harmful effects on the host plant. Fungal endophytes are known to produce a wide range of bioactive compounds with several biological activities, including neuroprotective effects. Neurodegenerative disorders lead to miscommunication between nerve cells, damage or loss in structure and function of the central nervous system (CNS) or peripheral nervous system (PNS). Reactive oxygen species, neuroinflammation, protein degradation or aggregation, familial history, mutation in mitochondrial genes, and aging contribute to neurodegenerative disorders. Plant-associated fungal endophytes produce bioactive compounds, which show anti-neuroinflammatory, antioxidant, and anti-cholinesterase activities. Several pro-inflammatory (TNF-α and NF-κB) and depressant (serotonin, dopamine, and noradrenaline) molecules or neuronal signaling pathways leading to neurodegenerative disorders are known to be inhibited or down-regulated by fungal endophyte-derived bioactive compounds. Therefore, bioactive compounds produced from fungal endophytes could be a promising approach to treating various health&nbsp;ailments. The present chapter discusses selected fungal endophyte-derived potential bioactive compounds with neuroprotective effects for managing neurodegenerative disorders.<br>]]></description> </item><item><title><![CDATA[Modulations of SIRTUINs and Management of Brain Disorders]]></title><link>https://www.benthamscience.comchapter/18772</link><description><![CDATA[Neurodegenerative disorders are the conditions in which neurons of the central and peripheral nervous systems degenerate. Various cellular and molecular processes are associated with the progression of such degeneration, including inflammation, apoptosis, and axonal degeneration. Recently, SIRTUINs have emerged as one of the key factors associated with neurodegenerative disorders. SIRTUINs are involved in the regulation of several cellular and molecular processes in neurons of the nervous system through the deacetylation of target proteins. The chapter focuses on the modulatory role of SIRTUINs in neurodegenerative disorders and their potential therapeutic application.&nbsp;<br>]]></description> </item><item><title><![CDATA[Delineating the Neuroinflammatory Crosstalk in Neurodegeneration and Probing the Near Future Therapeutics]]></title><link>https://www.benthamscience.comchapter/18771</link><description><![CDATA[Neurodegenerative disorders are threatening mankind with significant health and economic burden. Neurodegeneration involves the deterioration of neurons in the central nervous system (CNS), resulting in decreased neuronal survival. Therefore, it is of utmost requirement to develop a promising pharmacological strategy to minimize or prevent the progression of the underlying disease pathogenesis. In neurodegenerative disease conditions, neurons and glial cells present in the specific brain regions are damaged and depraved, resulting in specified disease symptoms in the patients. Neuroinflammation plays a major role in the degeneration of neuronal cells by regulating the expression of interleukin-1 beta (IL-1β), IL-6, IL-8, IL-33, tumor necrosis factor-alpha (TNF-α), chemokines Cxcl3 (C-C motif) ligand 2 (CCL2), CXCL5, granulocyte-macrophage colony-stimulating factor (GM-CSF), glia maturation factor (GMF), substance P, reactive oxygen species (ROS), reactive nitrogen species (RNS), impaired tuning of immune cells and nuclear factor kappa-B (NF-κB). Considering this, it is very important to understand the in-depth role of neuroinflammation in the initiation and progression of various neurodegenerative diseases, including Alzheimer's Disease (AD), Parkinson's Disease (PD), Huntington's Disease (HD), as well as Multiple Sclerosis (MS). Recent shreds of evidence have suggested that using exogenous ligands to approach various biological molecules or cellular functioning that modulates the neuroinflammation, such as microglia response, P2X7 receptors, TLR receptors, oxidative stress, PPARγ, NF-κB signaling pathway, NLRP3 inflammasome, caspase-1 signaling pathway, and mitochondrial dysfunction, helps to combat neurodegeneration in a variety of diseases. Thus, targeting the neuroinflammatory drive could provide a beacon for the management of neurodegenerative diseases. Here, we have attempted to provide comprehensive literature suggesting the role of neuroinflammation in neurodegeneration and its implication in the development of near-future neurotherapeutics.<br>]]></description> </item><item><title><![CDATA[Parkinson's Disease: A Phytotherapeutic Prospective]]></title><link>https://www.benthamscience.comchapter/18770</link><description><![CDATA[Parkinson's disease (PD) is a complex multi-factorial, neurodegenerative disease characterized by neurodegeneration of dopaminergic neurons in the substantia nigra (SN) of the ventral midbrain area. Loss of dopamine (DA) supply induces an imbalance of multiple neurotransmitter networks in different parts of the brain. This contributes to many motor and non-motor symptoms in PD. The main goal of modern allopathic medicine is to restore DA function with synthetic levodopa (L-DOPA) and DA agonist, which has been partially effective; however, there are still several inadequacies and adverse effects that patients often cannot cope with. In the field of herbal medicine, extensive studies on bioactive phytocompounds have shown that it has immense potential as a neuroprotective therapy for neurodegenerative disorders, such as PD. Bioactive phytocompounds are very promising because they have minimal side effects and very high anti-inflammatory, anti-oxidant, and anticholinesterase activity. Recent preclinical studies suggest that several bioactive phytocompounds can be developed into pharmaceutical formulations for the treatment of PD. Ayurvedic medicines have been used in many countries and particularly in India since ancient times to prevent or cure PD. This article focuses on the recent evidence-based neuroprotective activity of medicinal plants like Mucuna pruriens, Curcuma longa, Zingiber officinale, Bacopa monnieri, Nardostachys jatamansi, Withania somnifera, and Silybum marianum in in vivo and in vitro PD research models.<br>]]></description> </item><item><title><![CDATA[Current Approaches to Antimicrobial Formulations and their Delivery]]></title><link>https://www.benthamscience.comchapter/18764</link><description><![CDATA[With the escalating concerns about antimicrobial resistance and the intractable nature of microbial infections, there is a demand for the expansion and development of alternative stratagems for treating microbial diseases. At present, the advent of antimicrobial resistance amidst microbial pathogens, especially the ‘drugresistant’ ones, has led to poor clinical consequences, thus, shooting up healthcare outlays and mortality. Moreover, the formation of biofilms-like assemblies by microorganisms and their surface association mechanisms have led to secondary infections in immunocompromised individuals and further muddled the prophylaxis. Such microbial resistance is primarily attributed to the inapt and undue use of antimicrobials in humans/animals and the unregulated administration of these drug formulations. Therefore, there is an urgent need to propose and imbibe various modern, multifaceted antimicrobial formulation approaches to prevent the fatal consequences of antibiotic resistance and enhance the effectiveness of microbial growth control. Currently, several new-age antimicrobial formulation therapies are being explored and have shown promising results as efficacious preventatives, diagnostics, and drug carriers in comparison to conventional antibiotic therapy being used. In this chapter, we highlight the different categories of new-age antimicrobial formulation therapies currently in use, their molecular mechanism of microbial targeted delivery, their effectiveness over the traditional therapies, the challenges in their development and the future outcome of these contemporary formulations.<br>]]></description> </item><item><title><![CDATA[Advent of Pharmabiotics as a Promising Therapeutic Tool for Human Health and Diseases Management]]></title><link>https://www.benthamscience.comchapter/18674</link><description><![CDATA[With the recent advances in understanding the role of the gut microbiome and human health, it has become evident that pharmabiotics have huge potential in the therapeutics as well as supplement industries for conditions leading to impaired microbiota. Pharmabiotics can be referred to as a class of microbial therapeutic probiotics which could be live bacterial cells of human origin or their products with clinically proven pharmacological activities found to be beneficial in human disease conditions. So, the mechanism by which bacteria produce synergistic beneficial effects on health could help us to develop a scheme to understand the delicate relationship between the gut microbiome and human health. In this chapter, we will emphasize the role of gut microbiota, the pharmabiotics they produce and how it affects different physiological and metabolic and host-microbe interactions leading to the production of bioactive chemicals with health benefits, eventually leading to the establishment of a healthy immune system. The chapter will also discuss the repercussions of disturbed gut microbiota on overall human health, including host psychiatric health. The fact that pharmabiotics acting as antimicrobial agents will produce no resistant variety is also an added bonus that increases the scope for discovery of such novel therapeutic agents.<br>]]></description> </item><item><title><![CDATA[Nanomedicine Technology Trends in Pharmacology]]></title><link>https://www.benthamscience.comchapter/18649</link><description><![CDATA[Nanotechnology deals with materials that are 1–100 nm in size. Nanomaterials are prepared in different ways such as physical, chemical, and biological methods. They exhibit fascinating features that allow them to perform numerous physiological tasks. They have higher surface area to volume ratios and show typical nanoscale quantum confinement characteristics. They play a critical role in biomedical research. They're quite versatile and used in a variety of medical applications. The demand for nanomedicine drugs with improved performance and reduced toxicity has been steadily increasing in recent years. Nanomedicine is the new area of nanoscience and nanotechnology. Pharmaceutical nanosystems are classified, synthesized, and characterized using procedures based on their size, shape, and functionality. This book chapter focuses on recent trends of nanomedicine technology in pharmacology, particularly on the application of nanomaterials in medicine. Antibacterial characteristics, multicolor medical imaging, disease diagnostics, medication administration, vaccines and biomolecules (peptides, proteins, and genes), therapies, cancer treatment, tissue engineering, and clinical aspects are discussed. Advancements in nanomedicine technology will not only aid in the early diagnosis of infectious and viral disorders, but also in the treatment of infections such as Alzheimer's disease, tuberculosis, and Parkinson's disease. The benefits and constraints of commercializing nanomedicine technology products for pharmacology applications, as well as the hazards and obstacles in developing nanomaterials for medical research are highlighted in this chapter.<br>]]></description> </item><item><title><![CDATA[Circulating Tumour Cells in Solid Cancer]]></title><link>https://www.benthamscience.comchapter/18577</link><description><![CDATA[Circulating tumour cells (CTCs), as 'liquid biopsy”, has a major benefit over traditional tissue biopsy and has the potential to become a less invasive and more costeffective cancer biomarker. The presence of CTCs in the circulation indicates the presence of a tumour and the possibility of metastatic spread. Hence, the characterisation of CTCs is expected to provide crucial insights into the mechanisms of metastasis. It can also provide useful information about the future use of CTCs as a surrogate endpoint biomarker in diagnosis, prognosis, and treatment response prediction by minimizing the limitations of tissue biopsies. Also, it provides a new horizon for the development of novel targeted therapies. However, the lack of specific and effective methods is the key limitation in CTC detection and isolation in patients with cancer. Therefore, more responsive methods and approaches may be needed to improve the accuracy of CTC measurements. Herein, this book chapter will provide a current picture of CTCs as surrogate biomarkers for disease diagnosis, prognosis and predicting therapy response, along with the risk of relapse in cancers.<br>]]></description> </item><item><title><![CDATA[Some Aspects of Pathology and Pathogenesis of Coronavirus Infection]]></title><link>https://www.benthamscience.comchapter/18415</link><description><![CDATA[This chapter presents an overview of pathology and pathogenesis in coronavirus infections in humans and animals based on literary data and our own experience, illustrated by numerous original images.&nbsp;<br>]]></description> </item></channel></rss>